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ABSTRACT 
Distribution of Mycobacterium tuberculosis lineages, Overview in Northern - Vietnam 
 
Author:   Pham Trung M.D. 
Supervisors: Gunnar Bjune, Prof., M.D., Ph.D.;  Ulf R. Dahle, Senior scientist 
Co-supervisors:  Vu Tan Trao, Ass. Prof., M.D., Ph.D.;  Bui Duc Duong, M.D., Ph.D.  
Sponsor:  University of Oslo, Faculty of Medicine, Institute of General Practice and 
Community Medicine, Section for International Health. 
Vietnam was among the high-burden tuberculosis countries. Molecular typing is not available 
on a routine basis in the Vietnamese National Tuberculosis Program’s laboratories.  DNA 
fingerprinting of Mycobacterium tuberculosis is an international standard epidemiologic tool, 
which exploits variability in both the number and genomic position of Insertion Sequence 
6110. This method allows generating strain specific DNA patterns (DNA fingerprints).  
Besides, IS6110-Restriction Fragment Length Polymorphism (RFLP) analysis has proven 
useful for the recognition of outbreaks in communities, modes transmission and 
determination of genetic diversity in M. tuberculosis populations world-wide.  To understand 
“Emerging strains” of M. tuberculosis and their epidemiology and distribution, RFLP studies 
are considered valuable for the public health aspects of the Vietnamese National Tuberculosis 
Program.   
Sputum smears collected, AFB microscopy performed and M. tuberculosis strains were 
grown on Löwenstein-Jensen slants for 4 to 6 weeks at local hospitals.   
PCR was used to detect M. tuberculosis DNA and a probe hybridization technique was used 
for genotyping.  DNA was extracted, digested and separated by using horizontal 0.8% 
agarose gels in Tris-acetate buffer and vacuum blotted onto nylon membranes. For the IS6110 
RFLP, the DNA was hybridized to the 254-bp PCR product of IS6110 and visualized by a 
digoxigenin-dUTP labelling and detection kit (Roche Diagnostics GmbH, Mannheim, 
Germany) in Norwegian Institute of Public Health (NIPH) in Norway.  
The sample size of this study was too small to make conclusive recommendations.  However, 
clear indications arise. The East African Indian family appears to represent a well established 
epidemic and presented an epidemiological pattern indicating recent transmission both within 
and between urban and rural areas. The Beijing and other families however, appeared to 
represent isolates of ongoing importation to northern of Vietnam.  Multi-drug resistance was 
not found to be related to any particular Mycobacterium tuberculosis family.   
Despite the presence of several M. tuberculosis lineages and the large genetic diversity in the 
MTB population presented in northern Vietnam, spoligotyping should be considered valuable 
screening method for clustering of M. tuberculosis isolates and their assignment to known 
genotypes. Also the affordability reproducibility of the method is in its advantage. 
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I. INTRODUCTION 
 
Annually, Mycobacterium tuberculosis (MTB) caused about 9 million new cases of active 
tuberculosis (TB) and 2 million deaths.  It is estimated that over one-third of the world 
population (1.9 billion people) was infected with TB and 80% of them are from 22 high 
burden countries.  TB can spread through the air, is contagious, a worldwide pandemic, 
multi-drug-resistant (MDR) and is the leading infectious disease cause of death among adults 
(15-59 years) (1;2).   Nowadays, TB epidemic is still growing in sub-Saharan Africa which is 
also closely linked to HIV/AIDS, intravenous drug-users and in developing countries. HIV 
infection worsen the TB situation by increasing reactivation of latent TB infection  as well as 
rapid progression of new infection in the HIV infected (3;4).    
 
To combat TB, Directly Observed Treatment, Short-course (DOTS) has been adopted as the 
WHO strategy for the global control of TB.  Besides, bacille Calmette-Guérin (BCG) is the 
only currently available vaccine against TB and widely administered in the WHO Expanded 
Program for Immunization (EPI).  BCG has been used to prevent of severe childhood disease 
but it has offered no overall protection in adult and a low level of overall protection in 
children, and not expected to reduce the transmission due to TB (2;5).   
 
The development of molecular typing techniques and its valuable methods in last decade has 
contributed to the improvement in studies of infectious diseases in general and TB in 
particular.  Molecular techniques can be used to discriminate exogenous versus endogenous 
disease, to investigate outbreaks, to study transmission within defined geographic setting, to 
detect MTB strain acquired MDR (6).  DNA fingerprinting of Mycobacterium tuberculosis 
has been shown to be a powerful epidemiologic tool. It is a standardized technique which 
exploits variability in both the number and genomic position of IS6110 to generate strain-
specific patterns (7).  Restriction fragment length polymorphism (RFLP) analysis with the 
IS6110 probe is a convenient and reliable method for differentiating M. tuberculosis strains 
(8).  A total of 36 potential subfamilies or subclades of MTB complex have been tentatively 
identified and devided into 8 main families worldwide (9;10)  Beijing strain is a new 
successful strain of MTB, representing a high percentage of clinical isolates in South East 
Asia, South Africa and several locations in the Russia Federation, in newly diagnosed 
patients Beijing was strongly associated with MDR (11).   
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Vietnam is a member of high burden countries with approximately 145,000 new cases of TB 
each year of which about 20,000 deaths are due to TB-related causes (12).  Vietnam is the 
only member of the current group of high-burden countries who has reached the targets for 
DOTS implementation before the year 2000. TB prevalence was 232 (all cases / 100,000 
pop.), incidence 176 (all cases / 100,000 pop.), new TB cases MDR 2.3 %, previously treated 
TB cases MDR 13% (WHO estimated 2004).  Some scientific studies showed that molecular 
techniques had been conducted in Pham Ngoc Thach hospital, Ho Chi Minh City, however, 
they were not used as routine activities in the reference laboratories of NTP.   On the other 
hand, those studies had mostly focused on specific genotype, such as Beijing strain by 
spoligotyping method.  Thus, this study research aims to describe the distribution of MTB in 
the northern of Vietnam. The combination of spoligotyping and IS6110 RFLP as probe can 
discriminate exogenous versus endogenous strains as well as demonstrate the transmission 
between patients living in different geographical areas, and generate strains specific patterns 
of MTB at the same time.   Besides, this study has an opportunity to review sputum smear 
microscopy technique using bacterial culture as gold standard in screening TB.    
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II. LITERATURE REVIEW 
 
 
Epidemiology of TB 
 
2.1  Epidemiology basis of TB:  To facilitate the understanding of the relevance of the 
epidemiology of tuberculosis as a basis for implementing a successful national TB control 
program, a model following the pathogenesis of tuberculosis from exposure to death is 
useful. 
 
 
 
 
A model for tuberculosis epidemiology, following the pathogenesis of tuberculosis (Hans L. Rieder) (13). 
 
 TB suspect:  As illness, TB mainly affects the lungs, but it also affect to other parts of the 
body, such as brain, bones, glands, etc.  TB should be suspected if a person has cough for 
three weeks or more. TB is caused by the germs spread through the air when the infected 
persons cough or sneeze.  People who are infected with do not feel sick, do not have any 
symptoms, and can not spread TB.  They may develop disease at certain time in the future. 
People with TB can be treated and cured if they seek medical help. Besides coughing, other 
symptoms of TB may include fever, especially rising in the evening, pain in the chest, loss of 
weight, loss of appetite, coughing up of blood (14). 
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2.2 Laboratory: 
 
Sputum smear microscopy for acid-fast bacilli (AFB) remains the first priority for National 
Tuberculosis Programs (NTP) in high-prevalence countries (13). 
 
Tuberculin Skin Test (TST) usually positive in adults in endemic area of TB. It demonstrates 
that at some point in the past the person was infected with Mycrobacterium. It is, therefore of 
limited diagnostic value for active TB.  A tuberculin reaction of >= 5 mm of in duration is 
generally regarded as positive (15). 
 
Culture:  Bacteriological culture provides the definitive and remains the gold standard for 
diagnosis of tuberculosis.  Culture techniques can detect few bacilli (AFB negative cases); 
diagnosis failures of treatment; provide material for drug susceptibility testing, PCR and 
DNA fingerprinting (16). 
 
Chest X-ray (CXR) may show evidence of active or healed TB manifestation in the lungs.  It 
may also reveal clustered calcifications in the axilla, suggesting the possibility of lymph node 
tuberculosis in suspected patients  (17). 
 
Drug Susceptibility Test (DST):  Drug susceptibility compares the growth rate in drug free 
and drug containing media; detects or measures of the metabolic activity of isolates and 
genetic mutations using molecular techniques (18).  DST is used as a tool for selection of 
effective regimens to successfully treat tuberculosis patients, evaluate NTP efficiency. 
 
2.3 Molecular Epidemiology 
Polymerase Chain Reaction (PCR):  Gene amplification methods are designed for the 
detection of MTB is highly sensitive, especially culture-negative specimens of the disease. A 
variety of PCR techniques have been developed for the detection of specific sequences of 
MTB and other Mycobacterium species (19).  PCR defined segments of DNA can be 
amplified to microgram quantities from as little as a single template molecule.  Although the 
procedure in some way is deceptively simple, and the reaction can entail complex 
biochemical interactions, it is in most applications a fast, relatively inexpensive, and easy 
way to generate sample materials for further analysis (20). 
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Spoligotyping detects and type MTB complex bacteria, based on polymerase chain reaction 
(PCR) amplification of a highly polymorphic direct repeat (DR) locus in the MTB genome.  
Spoligotyping determines causative bacterium and provide epidemiologic information on 
strain identity.  It is useful in surveillance of TB transmission and to measure the 
interventions to prevent further spread of the disease (21).    
 
 (22)  
 
 
In comparison to other molecular typing techniques such as IS6110 RFLP, the advantage of 
spoligotyping is the relatively fast generation of DNA patterns, data can be digitalized 
therefore simply inter-laboratory comparisons and communication of results.  Also it can be 
performed directly on cell lysates and nonviable bacteria.  The limitation is mainly related to 
its inferior discriminatory power (23).   
 
In the “the fourth international spoligotyping database” (10), the population genetics of 
39,295 strains from 122 countries were identified, some main TB families/lineages were 
described.  A different in eight regions of the world are described below: 
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The Central-Asia (CAS) family was essentially localized in the middle-East and Central Asia 
(21.2%), and preferentially in India (75%). 
Haarlem (H) family was distributed 25% of the isolates globally while it dominated in South 
America by constituting around 50% of the isolates there. 
Latin-American-Mediterranean (LAM) constituted 50% of the other haft of the strains from 
South America. 
The “T” family is less well defined and include more than 600 unclassified STs.  This lineage 
is currently stratified into 5 sub-clades (T1-T5).  
East-Africa-India (EAI) family was more abundant in South-East Asia, particular in Vietnam 
and Thai Lan (32%). 
X family was highly prevalent in North America (21.5%) and Central American (11.9%) 
regions.  
The Beijing and Beijing related strains represented about 50% of the strains in Far East- Asia 
and 13% of isolates globally.   
 
Spoligotyping has been shown to exhibit less discriminatory power than IS6110 RFLP when 
used for sub-typing of high-copy-number strains but has proven useful for sub-typing IS6110 
low-copy-number strains (24). 
 
Restriction Fragment Length Polymorphic (RFLP) technique may be differentiated by 
analysis the diversity degree and the distribution of isolates when the DNA is digested with a 
restriction enzyme.  Clinical isolates of MTB studied with IS6110 – RFLP typing display a 
high degree of polymorphism and long term stability of RFLP has been demonstrated (8).   
The IS6110 RFLP base on the differences between strains in the number and position of 
copies of IS6110, ranging from 0 to 25 in the chromosome (25).  Currently, IS6110 RFLP has 
been widely used in TB epidemiology in order to answer question related to the transmission, 
re-infection or reactivation of MTB (26).  However, there are some limitations to the IS6110 
RFLP technique.  The method is unreliable for typing strains with fewer than 6 copies of 
IS6110.  Also the method is laborious, require high tech laboratory equipment and skill, and 
it represents a difficulty for communication results and inter-laboratory comparative analysis 
(23;25;27;28). 
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RFLP analysis diagram (23) 
 
 
2.4 Transmission and pathogenesis of TB 
In natural circumstances, MTB is transmitted by expulsion of exhaled droplets from an 
infected human individual to an uninfected one. Air-born droplets produced when patients 
cough, sneeze, speak, sing etc.  They may contain tubercle bacilli and are no larger than 2 μm 
in diameter.  These droplets are able to penetrate to the alveoli of the respiratory tract of the 
uninfected individual (29;30). Tubercle bacilli are necessary, but not sufficient cause TB. 
While the risk of becoming infected is largely exogenous in nature, determined by the 
characteristics of the source case, environment, and duration of exposure, the risk of 
developing TB given that infection has occurred, is largely endogenous, determined by the 
integrity of the cellular immune system (13). 
Alveolar macrophages ingest the MTB and enclose them in phagosomes. If these 
macrophages are activated, the mycobacteria containing phagosomes fuse with lysosomes, 
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and the bacteria are killed. If the alveolar macrophages are not activated, the bacilli survive 
and grow within the phagosomes by altering intracellular compartments in some way to 
preclude normal maturation to phagosomes or to prevent fusions of the phagosomes to 
lysosomes (29;31). Ingested tubercle bacilli by other alveolar and monocyte are spread 
through lymphatic channels to regional hilar and mediastinal lymph nodes and through 
bloodstream to other organs.  The logarithmic phase of bacillary growth is arrested with 
development of cell mediated immunity and delayed-type hypersensitivity at 2-10 weeks 
after the initial infection (29;32).  Development of specific immunity is usually adequate to 
limit further multiplication of the bacilli; the host remains asymptomatic; and the 
manifestations heal.  Overall, 10% of people infected with MTB will develop clinical TB 
sometime during their life (Bass JB et al, 1999).  At any time after the initial infection, 
tubercle bacilli that have spread through the body may begin to replicate and produce disease.  
The infection of these lymph nodes may progress directly to clinical disease or may become 
active after years or never at all (33). 
 
2.5 Risk factors for develop active TB 
The importance of any risk factor in public health is determined by both the strength of the 
association and the prevalence of the risk factor in the population (13). 
 
Infection with the human immunodeficiency virus (HIV) and IDU:   The risk of TB in IDU 
varies with the duration of HIV infection, among HIV-infected persons is closely correlated 
with the number of CD4+ lymphocytes; in HIV-infected persons tuberculosis most often 
results from the reactivation of latent TB infection (4;34).  
 
Spontaneously healed TB with fibrotic residuals:  Persons who had TB which healed 
spontaneously leaving fibrotic residuals are at increased risk of developing TB again (35).   
 
Age:  There are large differences in tuberculosis incidence by age. Adolescents and young 
adults seem to be prone to progression from latent infection to disease while children around 
the age of 10 years least prone. Variation with stage of maturity is not as likely an 
explanation of the steady increase in incidence rates among adults up to the age of 60 years.  
However, there are indications that the risk of tuberculosis following infection increases 
beyond the age of 60 years (36-38). 
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Sex: Some recent studies suggest that maturational and hormonal factors may play a role in 
the risk of tuberculosis and its manifestations (37;39). 
 
Body build:  The incidence of TB among person below ideal body weight is higher than 
among person with normal height and weight (40). 
 
Environmental factors: 
Smoking:  TB incidence in smoker group higher than non - smoker group was presented 
in some studies (41). 
Chronic ethanol abuse in humans leads to a variety of immuno-modulatory events that 
can alter resistance to infectious agents, including TB (42).   
Nutrition 
It is a common notion that malnutrition adversely affects the immune system. 
Diet:  Vegetarian diet has been identified as a risk factor for TB (43).  The active 
metabolite of vitamin D, 1,25-hydroxy-vitamin D3, promotes maturation and activation of 
human monocytes and macrophages, and its inhibitory activity on multiplication of 
virulent tubercle bacilli in human macrophages has been demonstrated (44). 
 
Medical conditions 
The severity of silicosis diagnosed at necropsy was associated with increasing risk of 
pulmonary TB (45).  The incidence of TB among diabetics group was higher than general 
group (46). 
 
Factors associated with the etiologic agent 
Infecting dose effect 
Strain virulence: Patients with multi-drug resistant strains will remain infectious for a 
longer time on average than with patients with fully susceptible organisms, as 
chemotherapy is likely to be less efficient in rapidly reducing transmissibility.  It seems to 
be confirmed that certain genetic mutations in tubercle bacilli which cause them to 
become isoniazid-resistant also reduce their virulence in experimental animals (13). 
 
Re-infection and multi-drugs resistant (MDR): The cured patients developed TB disease 
again with a resistant strain has proven in some previous study.  Besides, resistance to anti-
tuberculoses drugs can develop not only in the strain that caused the initial disease, but also 
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as a result of re-infection with a new strain of M. tuberculosis that is drug-resistant (47). 
 
Socio-Economic-Status (SES) impacts TB incidence via both a strong direct of crowding, 
manifested predominantly in overcrowded setting, and a TB – SES health gradient, 
manifested at all SES level (48).  
 
 
2.6 Treatment 
To combat TB, WHO has recommended adoption of a new strategy called Directly Observed 
Therapy Short-course (DOTS). This strategy has five elements, each of which is essential: 
- Clear and sustained political commitment by national governments is crucial if basic 
DOTS and the Stop TB Strategy are to be effectively implemented. 
- Case detection through quality-assured bacteriology:  bacteriology remains the 
recommended method of TB case detection, first using AFB microscopy and then 
culture and DST testing. 
- Standardized treatment, with supervision and patient support. 
- An effective drug supply and management system. 
- Monitoring and evaluation system, and impact measurement. 
The DOTS strategy emphasizes completion of treatment and thereby curing of the patient. By 
doing so, it stops TB at the source, and prevents the spread of the disease, the development of 
MDR-TB, and complications of TB, relapse and death. 
WHO-recommended strategy prolongs survival of patients with AIDS and TB and improves 
their quality of life. It can be integrated into the general health services and can, therefore, be 
widely used. The global target for TB control is to cure at least 85% of new smear positive 
cases and detect at least 70% of such cases.  DOTS is the only strategy which has achieved 
these results on a program basis (49). 
DOTS program will have greater effect on TB incidence if it detects cases of infectious and 
noninfectious TB as soon as possible. The proportion of deaths prevented will generally be 
greater than the proportion of cases prevented, especially if cure rates have been low in the 
past and the new program treats smear negative cases (50). 
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BCG vaccine 
BCG vaccines are generally given to protect against TB. Though the WHO now emphasizes 
BCG’s utility in prevention of severe childhood disease (e.g. TB meningitis), the main public 
health burden of TB is associated with adult pulmonary disease.  It is therefore important to 
consider BCG vaccine efficacy against childhood TB, separate from adult TB. 
Booster doses:  some studies conducted in Hungary, Poland, Chile and Finland showed that 
there is no convincing evidence that boosters are effective in preventing TB (51). 
  
2.7 Emerging successful strain  
The high prevalence of Beijing strains globally demonstrate that the success of MTB strains 
type as a human pathogenic (Glynn et al.,2002) (52;53).  The genetic of this family was 
described in 1995, and has been shown to be a highly prevalence in China, Russia, north of 
America, and other Asian countries. Beijing family strain was significantly related with 
young TB patients.    In addition, the characteristics of Beijing strains that emerging because 
they have a higher ability to resist the anti-TB drugs and/or BCG vaccination has been shown 
in many studies (11;47;52-58).  
 In the case of the Beijing trains, it has shown high prevalence worldwide; resist anti-TB 
drugs and/or BCG vaccination and wide transmission; relatives to young TB patients as 
mention above Beijing strain is a new successful strain of MTB (11). 
Beijing molecular typing definition:  Beijing genotype strains, including W strains, have been 
characterized by their highly similar multi-copy IS6110 restriction fragment length 
polymorphism (RFLP) patterns, deletion of spacers 1 to 34 in the direct repeat region 
(Beijing spoligotype), and insertion of IS6110 in the genomic dnaA-dnaN locus (59). 
The percentage of low-copy number IS6110 RFLP of MTB was recorded at 26% originated 
from ASIA while 54% from Central and East Africa (Bauer, J et al 1999), however in this 
study the MTB strains was not described in genotype families (24;60).  
The definition of atypical Beijing is Beijing (spoligodefinition) strains carrying low copies of 
IS6110.  It is also based on polymorphism on other genes, but we do not routinely use them 
for characterization (61). 
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III.  COUNTRY PROFILE 
 
Back ground 
http://www.unicef.org/infobycountry/vietnam.html 
Vietnam is located in South-eastern Asia, bordering the 
Gulf of Thailand, Gulf of Tonkin, and South China Sea, 
China, Laos, and Cambodia. 
The climate is tropical in south; monsoonal in north with 
4 seasons (Spring, summer, autumn and winter)  
The environment: Slash-and-burn agricultural practices 
contribute to deforestation and soil degradation.  Water 
pollution and over fishing threaten marine life. 
Groundwater contamination limits potable water supply.  
Growing industrialization (and population migration) is 
rapidly in Hanoi and Ho Chi Minh City. The population 
growth rate is 1.3% (2004 estimated) and the age 
structure is 29.4% 0-15 years; 65% 15-64 years; 5.6% 
over 65 years. The Vietnamese population estimated in 
July 2004 is 82,689,000 (July 2004 est.)  (62). 
 
Hanoi profile:  The city is located on the right bank of the Red River.  Hanoi comprises nine 
inner districts and five outer districts.  Hanoi experiences the typical climate of northern 
Vietnam, where summers are hot and humid, and winters are relatively cool and dry.  The 
minimum winter temperature in Hanoi can dip as low as 6–7°C (43°F), while summer can get 
as hot as 38–40 (100-104°F).  Hanoi is the largest center of education in Vietnam. It 
estimated that 62 % of the whole country science cadres are living and working in Hanoi.  
Because many of Vietnam's major universities are located in Hanoi, students from other 
provinces wishing to enter university often travel to Hanoi for the annual entrance 
examination.  Hanoi's population is constantly growing, a reflection of the fact that the city is 
both a major metropolitan area of Northern Vietnam, and the country's political centre.  
Hanoi estimated population 3,145,300 (2005).  Hanoi has the highest Human Development 
Index among the cities in Vietnam. Though representing only 3.6 percent of the country's 
population and 0.3 percent of the national territory, Hanoi contributes 8 percent to the 
national GDP and 45 percent of the Red River Delta's economy.  Together with economic 
growth, Hanoi's appearance has also changed significantly, especially in recent years. 
Infrastructure is constantly being upgraded, with new roads and an improved public 
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transportation system.  There are about 10 big hospitals and hundreds health care facilities in 
Hanoi 
Thai Binh is a coastal east province in the Red River Delta region of Vietnam, it is about 18 
km from Nam Ðịnh, 70 km from Hải Phòng, and 110 km from Hà Nội. Thai Binh has a city 
called Thai Binh city and seven districts.  Thiamin estimated population 1,827,000 (2002), 
including 94.2 % countryside and 5.8% city residence.   The climate is as same as Hanoi city.  
The economic growth rapidly, in 2004 export turnover estimated 78 million USD (increased 
22%) while import turnover 57 million USD (increased 20.3%).  There were 27,500 tourists 
visited, including 2,800 foreigners in 2004.   
 
3.1  Healthcare system 
                                 
National Tuberculosis Control Program 
Anti-TB activities were started in the north as early as 1957 and extended to the south after 
the country's reunification in 1976. The National Tuberculosis Control Program (NTP) has 
begun applying the control model of International Union Against Tuberculosis and Lung 
Diseases (IUATLD) from 1996; this has been successful in many developing countries and is 
in compliance with the recommendations of the WHO. This model has been deployed and 
integrated into the network of health services from the commune level to the district and 
provincial levels. Thus, TB diagnosis and treatment are carried out by commune and district 
health workers. The TB control program has wide population coverage:  In 1998, nearly 99 
percent of the Vietnamese population were living in communes and wards covered by the 
NTP. In 1986, population coverage was only 23 percent.  In addition to extensive coverage, 
the program has been successful in achieving 85 percent cure rate among all detected smear-
positive cases and has thus met the objectives set by the WHO (MoH 1999b). 
 
Expanded Program of Immunization 
Vietnam began implementing the Expanded Program of Immunization (EPI) on a pilot scale 
in 1982 and on a nationwide scale in 1985. Since 1993, the country has launched a campaign 
called the "National Immunization Day," when over 99 percent of children less than five 
years of age are given two doses of oral polio vaccine (OPV). The EPI program has seen 
tremendous growth in immunization coverage since 1985 and coverage is now estimated in 
excess of 90 percent of full immunization for children under one year of age against six 
vaccine-preventable diseases: diphtheria, tetanus, pertussis, poliomyelitis, measles and TB.  
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Table below shows coverage rates against tuberculosis from 1980-2004 (63) 
  
 
 
The increased immunization coverage has been associated with a dramatic decline in child 
mortality from vaccine-preventable diseases (63).  
The main challenge to the program is expanding immunization coverage in the mountainous 
and remote border areas, where the difficult geographical terrain, low incomes, and large 
ethnic minority populations all contribute to relatively low rates of vaccination coverage (64). 
 
3.2 TB in Vietnam 
Vietnam is the only member of the current group of high-burden countries to have reached 
the targets for DOTS implementation, which were achieved before 2000 and exceeded 
subsequently.  This success was made possible by the effective integration of political 
commitment, international technical assistance and funding, and efficient community 
mobilization. Viet Nam has continued to expand the program so as to reach remote 
population groups who have not had access to TB services, and to strengthen the diagnostic 
laboratory network. An urgent priority is the development of a national plan for improved 
TB/HIV coordination. A planned national TB prevalence survey will be of critical 
importance for measuring the impact of DOTS on the TB epidemic (MoH 1999b).  
 
System of TB control 
The National Tuberculosis and Respiratory Diseases Hospital (NTRH), in Hanoi, is 
 22
responsible for the activities for all of Viet Nam. Pham Ngoc Thach Hospital in Ho Chi Minh 
City is appointed to supervise the activities for the southern provinces. Each province has a 
provincial TB centre, under the direction of the provincial health service, which is 
responsible for the local implementation of the TB control program.  The district TB units, 
directed by the district health centres, coordinate the operation of peripheral TB activities. TB 
patients are referred to the district health centres from community health posts for sputum 
examination and initial treatment. An effective national TB laboratory network operates 
under the supervision of the NTP. There are two reference laboratories (Hanoi and Ho Chi 
Minh City) that perform culture and DST. Of the 64 provincial TB laboratories, nearly one 
quarter perform culture. Smear microscopy services are provided by more than 600 district 
TB laboratories (MoH 1999b). 
 
Surveillance and monitoring 
The best estimates of case detection for 2003 (86%) and treatment success for the 2002 
cohort (92%) suggest, as in previous years, that Vietnam has exceeded the targets for DOTS 
implementation. Given the high case detection and cure rates since 1997, a fall in the 
incidence rate could be expected, reflected in the trend in case notifications. It is unclear why 
no such decline is visible in the nationally aggregated data, but analysis by province could be 
more illuminating.  Case-notification rates are highest among elderly men and women; 
suggesting that TB incidence has been higher in the past. It is possible that incidence is not 
falling perceptibly in Viet Nam because the case detection rate may be lower, and the 
incidence rate higher, than the WHO estimates.  In this context, Vietnam’s long planned 
prevalence survey, improve long diagnosis delay condition and detect emerging successful 
strains would help to establish the true burden of TB in the country, as well as providing a 
baseline against which to evaluate the impact of the program on the TB epidemic (65). 
 
 23
OBJECTIVES OT THE STUDY 
 
Primary:    
 To contribute to the description of the MTB population in Northern Vietnam 
 
Secondary: 
To map out the difference in distribution of various MTB strains in urban and rural areas 
of northern Vietnam. 
 
To evaluate the combination of spoligotyping and IS6110 RFLP analysis, a Vietnameses 
MTB population 
 
Evaluate some current risk factor of TB disease in the north of Vietnam 
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IV. METHODS AND MATERIALS 
 
 
4.1 STUDY DESIGN AND SET UP:  Cross sectional analytic study 
Descriptive epidemiology is concerned with the distribution of the disease, including 
consideration of what populations or subgroups do or do not develop a disease, in what 
geographic locations it is more or less common, and how frequency of occurrence varies over 
time (66).  
 
Cross-sectional survey or prevalence survey provided information about the frequency and 
characteristics of a disease by furnishing a “snapshot” of the health experience of the 
population at a specific time and  the data can be used to describe characteristics of 
individuals with the disease and to formulate hypotheses, but not to test them (66;67).  Cross-
sectional studies establish association at most, not causality (68). 
 
In an observational analytic study, the investigator simply observes the natural course of 
event, noting who is exposed and non-exposed and who has and has not developed the 
outcome of interest (69). 
 
This was a cross-sectional and analytical study conducted in three hospitals (NTRH, HNTRH 
and TBTRH) located in two different cities namely:  Hanoi, capital of Vietnam, over three 
million inhabitants and Thaibinh province, with less inhabitant (see Country profile part).    
 
In this study, the defined population was from patients under 15 years and more than 40 years 
of age from Hanoi and rural areas in the northern of Vietnam admitted to the NTRH – 
HNTRH - TBTRH during the period from September to November 2006 by research team.  
In order to isolate MTB strains contribution, samples were collected from gastric aspirate 
(gastric liquid) in hospital of children population and from sputum smear of adult population 
into the study.  The researcher assume that, two above mention age groups differ to BCG 
vaccine status, in order to make clear the ability of BGC vaccination do or do not protect 
against emerging TB strains if possible (70). 
 
The samples processing and some of initial laboratory techniques (AFB, culture) were 
conducted in local hospitals.  DST was conducted in NTRH, which is currently a reference 
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laboratory of NTP.  All specimens were heat-killed by temperature and kept in a freezer 
before transport to NIPH, Norway, where the molecular analyses took place.  The National 
Institute of Hygiene and Epidemiology (NIHE) and Norwegian National Ethical committee 
approved this study. 
 
 
4.2 STUDY POPULATION 
 
Study population in the study was recruited from all patients admitted to NTRH, HNTRH and 
TBTRH from September to November 2006 and divided into 2 groups of under 15 years and 
over 40 years of age respectively.  All of them will be isolated MTB strains from samples 
collected by gastric aspiration (lavage) or sputum smear technique.  Gastric lavage collects 
the respiratory secretions which are swallowed by children at night (71). 
 
 
4.3 SAMPLE SELECTION 
 
4.3.1 Sample size 
With references from a previous study, conducted in 1998, Beijing genotype was found more 
frequently among BCG vaccinated than unvaccinated people.   However, the association in 
this study was not significant after adjusting for age (25;57), the percentage of Beijing strains 
was increased from 41% to 71 % (p>0.05; CI 95%) while the age of patients reduced from 65 
to less than 25 (57).  The researcher assumes that the percentage of W-Beijing strain 
appropriate at 80% and 50% among children under 15 years and adult over 40 years of age 
group respectively during the research study period.  How large and how does significant 
need to find out between the two groups?  The following formula has been used for sample 
size to calculate and determine the significant difference between the proportion of Beijing 
strain of patients under 15  and over 40 year old (72;73): 
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in which: p1 is the proportion Beijing cases among total TB patients under 15 years old    
p2  is the proportion Beijing cases among total TB patients over 40 years old     
α is significant statistic standard (level), probability getting error type I (reject Ho when 
it is true), it usually define at 0.1 or 0.05 or 0.01 correlative CI= 90% or 95% or 99% 
β is a probability getting error type II (accept Ho when it is false), it usually define at 0.1 
Z2 looks up from table below: 
  
Value of β Value of α 
0.05 0.1 0.2 0.5 
0.1 10.8 8.6 6.2 2.7 
0.05 13.0 10.5 7.9 3.8 
0.02 15.8 13.0 10.0 5.4 
0.01 17.8 14.9 11.7 6.6 
 
p1 and p2 were supposed to be 0.80  and 0.50. With 5% significance level and 80% power 
(then Z-square = 10.5) to detect a difference of 0.30 (or 30%) between the two groups we 
needed 48 subjects in each group. In all, the number subjects to be included were 96. 
 
 
The number of TB cases needed in each group (under 15 years and over 40 years of age) = 48 
In order to make the sample as large as possible, the convenient or accidental sampling is 
chosen to practice in this study.  
 
4.3.2 Sampling technique 
 
Convenience sampling method was applied in the study because it is relatively easy and 
inexpensive to conduct. By this way, two age group patients admitted to 3 hospitals were 
recruited into the study. The period of time to select subjects started from 1st September to 
30th November 2006.  MTB strains distribution were characterized by molecular analysis and 
used Bionumeric software combine visualized. All demographic, clinical, laboratory and 
response to treatment were analyzed by SPSS version 13. A data collection form was used for 
all patients.  Information was collected from patients or children parents/guardians. (Annex 2) 
 
Selection of cases 
All tuberculosis patients of the specific age groups were recruited into the study after they or 
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their parents/guardians had express the willingness to participate.  The willingness to 
participate by the patients themselves or parents/guardians was confirmed after the contents 
of the consent form (Annex 3) was read to them. 
 
TB patient’s diagnosis was confirmed by 3 hospitals.       
 
4.3.3 Inclusion and exclusion criteria 
Inclusion criteria 
All TB patients less than 15 years or over 40 years of age admitted to and confirmed by 3 
hospitals from September to November 2006 were eligible for the study.  
 
The MTB strains were collected from the patients before the treatment with anti TB drugs 
was prescribed. 
 
Exclusion criteria 
Patients were not willing to participate to the study. 
 
4.3.4 Data collection 
The pre-testing was conducted on 5 parents/guardians (mothers) of TB children less than 15 
years of age, in order to test the data collection forms.  They were not recruited into the main 
study after the selection of subjects. The idea was to check if they gave relevant answers to 
the questions to minimize information distortion.   
 
Seven research assistants were recruited into this study, three from NTRH, two from HNTRH 
and two from TBTRH. The questions and their meanings were thoroughly explained to the 
assistants. They were then instructed how to ask questions and how to report what the 
respondent answered. The assistants practised together to ensure a standardised way of 
collecting information.  
In the process of collecting data, the principal researcher and the assistants checked and 
qualified data after each day of data collection. Corrections were made as necessary and 
possible. 
 
 
The questionnaire (ANNEX 2) 
The questionnaire was first in English and was translated into Vietnamese language and 
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followed a clear and simple questions design. The questionnaire had open-ended and closed 
questions.  There was one questionnaire form in order to collect information from each 
patient. 
 
 
Data collection techniques 
Interviews 
Direct interviews were conducted on hospitalized patients. Interviewers first informed 
interviewees that participation in the study was voluntary.  The interviewers explained the 
purpose of the study and asked interviewees for their permission to interview and collect 
strains samples from the patients/themselves. Interviewees were also informed that the 
information they provided would be handled as confidential and their personal answers would 
not be known, except by the interviewer and the coordinator of this study.  
 
The interview obtained information about demographic data, symptoms of TB, treatment 
history and BCG vaccination status.    
 
Laboratory methods 
The diagnosis of TB in children remains a difficult one.  Children with pulmonary 
tuberculosis are usually unable to produce sputum, and gastric aspirates remain the procedure 
of choice for microbiologic confirmation of TB (74).  The standard approach to collecting 
gastric aspirates is to hospitalize the child and collect three aspirates on consecutive 
mornings. The expense of hospitalization and the variable yield from gastric aspirates 
discourages the routine collection of gastric aspirate from children suspected to have TB (75).  
Approximately 10 ml of gastric aspirate were collected into a sterile container in the early 
morning following an overnight fasting.  The aspirates were sent to the laboratory as soon as 
possible and process within 3 hours of collection. 
 
Samples (sputum and/or gastric liquid) were collected from patients at 3 hospitals in the 
period of the study.  Gastric lavage technique was conducted in NTRH with patients from 0 
to 5 years old only, depending on the availability of skilled staff.  
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4.4 Laboratory 
 
4.4.1   Acid-fast bacillus (AFB) microscopy: 
AFB microscopy used in this study as a standard method of Vietnam NTP according to the 
recommendation in the IUALTD and WHO guides.  3 sputum smears were obtained early 
morning after rising in the first 3 day of each adult hospitalized patient.   Ziehl-Neelsen 
(containing fuchsin 0.3%) was used as stain method, with 15 minutes of contact after heating.  
De-staining was used acid alcohol (3% hydrochloric acid in alcohol or 70% alcohol), and 20 
sulphuric acid in water.  Counterstaining was used methylene blue in a 0.3% concentration 
for maximum one minute.  3 experienced technicians were selected by head of microbiology 
department and the author of study, 1 from each hospital was been responsible for 
microscopic examination.  Recording and reporting was done by technician, the 
IUATLD/WHO scale was used as evaluation tool, in case the ordinary microscopy minimum 
1 AFB per 10 field or 10/100 was presented for 1+ result…(76) 
 
4.4.2 Culture: 
N-ACETYL-L-CYSTEIN-SODIUM HYDROXIDE (NACL-NAOH) was used in all of three 
hospitals in this study.  The mucolytic agent NACL (used for rapid digestion of sputum) 
enables the decontaminating agent (NAOH) was used at a lower final concentration of 1%.  
Sodium citrate is included in the digestant mixture to bind the heavy metal ions which may be 
present ij the specimen and could in active the acetyl-cysteine (16).  Samples were grown up 
from 3-5 weeks and killed by temperature, then were kept in freezer at (– 200C) before 
transportation to NIPH, Norway. 
 
4.4.3 Drug susceptibility testing (DST): 
The Proportion method was used in NRTH only, with LÖwenstein-Jensen (LJ) medium.  DST 
protocol was used in NTRH during the period of study according to the guideline of the 
WHO.  Resistance is expressed as the percentage of colonies that grow on critical 
concentrations of the substances, i.e. 0.2 mg/l for Isoniazid, 2 mg/l for Ethambutol, 4 mg/l for 
dihydro streptomycin sulfate, and 40 mg/l for Rifampicin if LJ medium has been used. The 
interpretation will be based on the usual criteria for resistance, i.e. 1% for all drugs.  (77). 
The LJ medium was used for all the resistance tests. The control (egg) medium without drugs 
was prepared at the same time as the drug-containing media. The period of validity of the 
media stored at 480C is 2 months.  
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DST was conducted at NTRH parallel with spoligotyping and RFLP techniques in Norway in 
the same time.   
 
4.4.4 Molecular typing 
 
PCR: In this study, the terminal region of the MTB genome, where direct repeats are located 
(namely A; B; C; D etc) will be amplified by primer DRa and primer DRb.  Amplification of 
the spacers are accomplished by using the primers DRa and DRb, which enable one to 
amplify all spacers between the DR sequences.  Only a small amount of template DNA is 
required.  Typically the PCR is performed on 10ng purified chromosomal mycobacterial 
DNA.  With minor adaptations, frozen DNA extracts from clinical samples can also serve as 
templates.  DRa is labelled with Biotin, ensuring incorporation of this marker in the final 
PCR product.  The primers of PCR are based on the DR sequences: 
DRa: 5’ – GGT TTT GGG TCT GAC GAC – 3’, biotinylated at 5’ end 
DRb: 5’ – CCG AGA GGG GAC GGA AAC – 3’ 
 
Spoligotyping is based on DNA polymorphism present at one particular chromosomal locus, 
the “Direct Repeat” (DR) region, which is uniquely present in MTB complex bacteria.  With 
the method described here, the presence or absence of 43 DR-spacers of known sequence can 
be detected by hybridization of PCR-amplified DNA to a set of immobilized 
oligonucleotides, representing each of the spacer DNA sequences. This method will be 
referred to as spoligotyping (from spacer oligotyping) (78). 
 
PCR products are hybridized perpendicular to the oligo lines.   After hybridization the 
membrance is incubated in streptavidin  peroxidase, which binds to the biotin label on the 
PCR products.  Hybridization signals are detected by the enhanced chemiluminescence 
(ECL) detection system.  The peroxidase present on the streptavidine catalyzes a reaction 
resulting in the emission of light (79). 
 
Isolation of high molecular weight genomic DNA from Mycobacteria 
The method of choice is determined by the amount of starting material, the desired amount 
and purity of the DNA isolated, and the nature of the materials from which the DNA is to be 
extracted.  DNA isolated by most miniprep protocols may contain -RNA contamination 
which can interfere with DNA digestion and with hybridization of the Southern blots.  RNA 
can be removed either by digestion of the entire sample with DNase-free RNase after 
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preparation, or at the same time as restriction endonuclease digestion (20). 
 
4.4.5 Molecular fingerprinting of MTB strains isolated using IS6110 as probe:  
IS6110 RFLP analysis  
Extraction of the chromosomal DNA from the MTB isolates and Southern blot experiments 
were performed according to the standardized protocol of Kristin Kremer et al (Annex 2)(80). 
DNA was digested with restriction endonuclease PvuII and hybridized with a 245 bp, PCR-
amplified DNA probe directed against the right arm of the IS6110. The probe was 
nonradioactively labeled with random primed DNA labeling with digoxigenin-dUTP, alkali-
labile and detection of hybrids by enzyme immunoassay (DIG). To facilitate the computer-
assisted comparison of the fingerprints, we used the PvuII-digested chromosomal DNA of 
MTB Mt14323 as a reference in each analysis (annex 2) and an external 1 kb molecular 
weight marker (81).  
The fingerprint patterns of the isolates were compared both by computer-assisted analyses 
using BioNumerics Version 1.5 software (Applied Maths, Kortrijk, Belgium), and by visual 
examination. All bands that were found to have similar RFLP patterns by computer analysis 
were visually compared and classified. A cluster was defined as a group of two or more 
strains from different patients, whose DNA fingerprints were identical with respect to both 
number and molecular size of all bands. Strains with unique DNA fingerprints were classified 
as non-clustered (82). 
 
4.5 Variables and definitions used in this study 
Two types of variables were used in the study, namely dependent and independent variables.  
 
Dependent variables 
MTB strains were characterized at the Norwegian Institute of Public Health (NIPH) Norway. 
 
Independent variables 
The independent variables in the study were regarded as the potential risk factors for TB 
based on the literature review, including demographic, socio-economic factors, transmission, 
drug resistant., BCG status… age, sex, smoking, alcohol, TST test etc of both of patients in 
different geographical (67).   
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4.6.  Data analysis 
 
Data collected were entered into a computer for analysis. SPSS 13.0 software for windows 
(Apache Software Foundation, release 1 Sep 2004, using LEADTOOLS © 1991-2000, 
LEAD Technologies, Inc) was used for the analysis of the data.  
Numerical variables such as age of patients were entered as they were without being recoded. 
In the other hand, categorical variables like sex, AFB positive or negative, culture, smoking, 
alcohol abuse, HIV test, TST test, etc, TB history were entered after being recoded. 
Categorization of clinical systems of TB was in 7 groups, no known symptoms, experienced 
symptoms 1 week, 1-4 weeks, 1-5 months, 6 months – 1year, and over 1 years.  The 
categorization was based on the period of symptoms presenting before the 1st day admitted to 
hospitals.  
Categorization of name of strains of TB confirmed by spoligotyping was filled as they were 
without recoded.   
Percentage, frequencies, cross-table were used as the tools of data presentation in a 
descriptive study, to given the number or proportion of time that observation occur in the 
study population as well as present discrete data;  
Bivariate analysis was performed to test the association of relative risk and TB, by 
calculating the OR and 95 % CI, with the statistical significance that was set at the level p < 
0.05. Multivariate analysis was then used to find out whether (or not) the factors, which were 
significantly identified in bivariate analysis, remain independently associated with the risk of 
TB(83). 
The fingerprint patterns of the isolates were compared both by computer-assisted analyses 
using BioNumerics Version 1.5 software (Applied Maths, Kortrijk, Belgium), and by visual 
examination. 
 
4.7  Ethical consideration. 
The researchers have to explain the purpose and benefits of the study to the subjects and ask 
them for their permission to interview and collect specimens. Participation in the study is 
totally voluntary. Participants will not be forced or persuaded to participate in the study. Even 
those who initially accept to participate are free to withdraw in the course of the study if they 
do not wish to continue.  The researchers have to guarantee the anonymity of the 
participants and the confidentiality of the information they provide. 
Since the study is conducted by asking patients recruited to gather information and collecting 
TB strains samples (gastric lavage or gastric aspirate), the conduct of the study will not pose 
 33
any health risk to the participants. 
 The study must be approved by the Department of International Health, Faculty of Medicine, 
University of Oslo-Norway and the Ministry of Health (MOH)-Vietnam. The project will be 
submitted to the two bodies for ethical clearance. Also, permission from NTRH directorate 
and local authorities (if needed) will be obtained before conducting the study. 
 
4.8 RESEARCH TEAM 
In collaboration between Department of Molecular Biology Laboratory-NIHE and 3 
hospitals, a research team was established to collect data for the study.  It included the 
principal researcher.   
 
4.9 TIME TABLE 
Month Works 
July - August  
2006 
- Visit and work with NTRH, HNTRH, TBTRH directorate 
- Recruit researcher assistants 
- Meet and discuss with all members of the research team to reach a 
consensus on the study’s schedule 
- Train interviewers and conduct the pre-testing. 
- Modify the questionnaire as necessary. 
- Arrange meetings for the research team to discuss and decide 
solutions to problems occurring in the process. 
September  -    Collect data and samples 
October  - Collect data and samples 
November  -     Collect data and samples 
December 2006 - Collect data and samples, and enter data into the computer 
January 2007 -    Transport heat killed MTB to NIPH, Norway to analysis 
February - April 
2007 
- Work in NIPH laboratory and collect data 
 
May – June 2007 
- Write thesis 
- Defend thesis 
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V. RESULTS OF THE STUDY 
 
5.1. Study population 
 
Among the patients, 74 were divided into two groups based on different characteristics of site 
of residence.  A total of 43 (58.1%) patients were from Hanoi (urban) and 31 (41.9%) resided 
in the surrounding provinces (rural)  
Patients were recruited between September and November 2006 at 3 hospitals: 
National Tuberculosis and Respiratory Diseases Hospital (NTRH) 
Hanoi Tuberculosis and Respiratory Diseases Hospital (HNTRH) 
Thaibinh Tuberculosis and Respiratory Diseases Hospital (TBTRH) 
 
Table 5.1: Gender and age group distribution by geographic 
 
 
Living place  Gender Age group Total 
  Children < 15 Adult > 40 M        F           
Hanoi  Male 0 36 36 
    Female 1 6 7 
  Total 1 42 43
Provinces  Male 2 19 21 
    Female 2 8 10 
  Total 4 27 31
 
 
Age distribution was presented a big different between adult and children in this study, 69 
(93.2%) adults versus 5 (6.8%) children.   
 
 
 
5.2 Clinical systems demonstration – Delay to diagnosis TB 
 
The period of clinical symptoms of patients was confirmed in the 1st day of admission to 
hospital.  During the first 1-6 months of clinical symptoms, the patients presented similar 
symptoms.  47.8% patients recorded sputum symptom during 1-6 month before diagnosis.  
(47.8% of cough, 37.7% of fever, 39.1% of chest pain, 44.9% of exhausted and 44.9% of lose 
weight).   
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Table 5.2: Distribution of cases by clinical symptoms  
 
 
 
5.3  Characteristics of the study samples by AFB and bacterial culture 
 
A total of 74 samples were collected from 3 hospitals inn the time of study.  Positive cultures 
were retrieved from 56 samples (51 belonged to adult and 5 belonged to children group).   
 
Table 5.3: AFB reviewed by using bacterial culture as gold standard  
 
  Culture Total 
  Positive Negative   
Sputum AFB Positive 54 4 58 
 Negative 2 14 16 
Total 56 18 74 
 
Assessing diagnostic test formula (83) 
Lose
weight
AxhaustedChest painFeverCoughSputum 
80 
60 
20 
0 
Cases
> 1 year
6-12 months
1-6 months
1-4 weeks
1 week
Yes 
No
Period of symptoms
Distribution of cases by clinical symptoms 
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Indicators were accounted: 
AFB false negatives = 2 / 56  = 0.035   AFB false positive = 4 / 18   = 0.222  
AFB sensitivity      = 54 / 56 = 0.964    AFB specificity     = 14 / 18 = 0.778 
Positive Predictive Value (PPV)  = 54 / 58 = 0.931  
Negative Predictive Value (NPV) = 14 / 16 = 0.875 
 
The AFB PPV 93.1% and NPV 87.5% mean that while those who tested positive, almost 
certainly AFB positive, among those who tested negative, few were AFB positive.  In a 
screening, this finding presented that most people would initially be truly diagnosed as TB. 
 
 
5.4   Characteristics of adult group: 
 
5.4.1  Demographic and socio-economic characteristic 
 
A total of 69 adult hospitalized patients were recruited in this study, including 42(60.9%) 
from Hanoi and 27 (39.1%) from provinces during September to November 2006.  In each 
group, the gender distribution was recorded of 36 (85.7%) male and 6 (14.3%) female from 
Hanoi group versus 19 male (70.4%) and 8 (29.6%) female form provinces group and all of 
them belong to King ethnic people.   The number of female was smaller than male in both 
Hanoi and province groups.   
 
19 (45.2%) patients of Hanoi were smokers while 13 (48.1%) of provinces and 22 (52.5%) 
alcohol abuses versus 17 (43.6%) respectively.   
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Table 5.4.1: Socio-demographic and clinical characteristic of adult group population by 
geography 
 
  Hanoi (urban) Provinces (rural) 
  Number % of group Number % of group 
Number of patients 42 100.0 27 100.0 
Age > 40 years Male 36 85.7 19 70.4 
 Female 6 14.3 8 29.6 
Ethnic Group Kinh 42 100.0 27 100.0 
Smoking  19 45.2 13 48.1 
Alcohol  22 52.5 17 43.6 
TB contact  5 11.9 2 7.4 
BCG history Vaccinated 1 2.4 0 0.0 
TB history  16 38.1 8 25.9 
Mantoux (TST) Positive 19 45.2 3 11.1 
 Negative 23 54.8 24 51.1 
Chest X-ray Symbolic 33 78.6 23 85.2 
HIV Positive 0 0.0 0 0.0 
 Negative 33 78.6 22 81.5 
 Not done 9 21.4 5 18.5 
AFB Positive 30 71.4 24 88.9 
 Negative 12 28.6 3 11.1 
Culture Positive 26 61.9 25 92.6 
 Negative 16 38.1 2 7.4 
 
5 (11.9%) patients from Hanoi and 2 (7.4%) patients from provinces are defined tuberculosis 
history in the past by interviewed and health book reviewed.  Only one BCG scar (2.4%) was 
found in Hanoi patient in this study.   
 
Tuberculin skin test (TST) was conducted for all of population in the first day of admission, 
19 (45.2%) positive and 23 (54.8%) negative cases were recorded in Hanoi group versus 3 
(11.1%) and 24 (88.9%) in provinces group respectively while TST positive was recorded 
67.8% and 32.2% negative in the whole of study population.  
 
33 (78.6%) patients in Hanoi and 23 (85.2%) patients in provinces were introduced active or 
healed tuberculosis lesion in their lungs by health workers (chest X-ray).   
 
33 (78.6%) Hanoi patients and 22 (81.5%) provinces patients were confirmed HIV negative 
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but the rest population was not conducted this test during study period.  30 (71.4%) Hanoi 
patients and 24 (88.9%) provinces patients were diagnosed AFB positive at least 1 of 3 
sputum samples, finally 26 (61.9%) and 25 (92.6%) positive cultures were collected from 
their population respectively. 
 
 
5.4.2 Distribution of samples by Provinces 
 
Among 56 positive M. tuberculosis cultures were isolated in Vietnam, 5 samples were 
isolated from children group, total 8.9% of collection.  The other 51 samples were isolated 
from adult group. 
 
In adult group, 26 (51%) were collected from Hanoi patients and 25 (49%) were isolated 
from patients residing in rural areas (5 provinces) in the North of Vietnam.  Data on 
distribution of samples by provinces are shown in figure 5.4 as below: 
 
Table 5.4.2:     Distribution of samples by Provinces 
 
 Frequency Percentage 
1 Hanoi 26 51 
2 Thai Binh 21 41 
3 Hai Phong 1 2 
4 Nam Dinh 1 2 
5 Bac Giang 1 2 
6 Thai Nguyen 1 2 
 Total 51 100 
 
 
Hanoi group:  The minimum age was 40 years and the maximum age was 79 years 
representing an age range of 39 years.  The median age was 51.5 years.  
Provinces group:  The minimum age was 41 years and the maximum age was 88 years 
representing an age range of 47 years.  The median age was 53.0 years.  
There was no significant difference of age distribution between Hanoi and provinces age 
group (CI 95%; interquartile range 28 and 26 respectively). 
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5.5 Molecular characteristic of the study MTB: 
 
A total of 56 samples were identified by spoligotyping and IS6110 RFLP as probe during the 
first quarter of 2007. 
 
5.5.1  Spoligotyping results 
 
A total of 48 samples were analyzed and the isolates were divided into two main lineages by 
spoligotyping.  The patterns are depicted in the diagram below: 
 
Table 5.2.1:  TB strains distribution were identified by Spoligotyping  
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The main first group included 18 samples identified as Beijing genotype The MTB Beijing 
genotype demonstrated hybridization to at least three of the spacers 35 to 43 in spoligotyping 
and showing an absence of hybridization to spacers 1 to 34 (59). 
 
A sample named Viet01N was recruited from one year children. 
 
 
In the second group: two globally prevalent lineages; East Africa India (EAI) and the “T” 
lineage were identified in large numbers.  
 
In subgroup 1:  Among the EAI lineages, 8 / 20 samples (from Viet11tb to Viet26tb) were 
identified as EAI4-VNM genotype. Phylogenetically and geographically this lineage appears 
specific for Vietnam and surrounding areas (absence of signals 26-27, 29-32 and 34). 3 
samples (from Viet15vvs to Viet64) belonged to the EAI-5 (absence of signals 29-32 and 34). 
The remaining 9 samples in this group were identified as EAI variants (general absence of 
signals 29-32 and 34) (10).  E.g.: a sample named Viet24tb belongs to the EAI1_SOM_EAI4 
((strain number 514, (84)) 
 
A sample named Viet03N was recruited from one year child. 
 
In subgroup 2:  7 / 9 samples were identified as “T” lineage (absence of signals 33-36) (10).  
Brudey et al presented that the “T” familiy (modern TB strains) stayed ill-defined with more 
than 600 unclassified STs.  They were stratified into 5 clades (T1-T5) based on the single-
spacer differences.  8 nested clades, with robust spoligotyping-signatures were extracted; 
with the exception of “Tuscany”, their names were built using their proximate upper-clade 
designation, followed by their presumed geographical specificity T3-Ethiopia, T5 – T1 
Russia, T3-Osaka, T4-Central Europe…(10).  Besides, 3 of 7 above mention samples (from 
Viet02N to Viet30tb) have been identified as T1 lineages. 
 
A sample named Viet11 belongs to the Latin-America-Mediterranean 9 lineage (LAM 9) and 
the sample named Viet11vvs belongs to the H3 LAM9 (ref. 335 – additional database).  They 
have been identified as LAM9 lineages (absence of signals 21-24 and 33-36), but Viet11vvs 
also carry the characteristics of the H3 lineages (absence of signals 31, 33-36) and this 
sample was designed of H3LAM9 lineage (10).   
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2 samples named Viet02N and Viet04N were recruited from one and two years old children. 
 
At last, there was a sample named Viet05N (undesignated) was recruited from a 9 years old 
children (with previously not described spoligpattern – absence of signals 28-31, 33-36 and 
40-43).  Its genotype characteristic defined by spoligotyping did not match previously 
described MTB genotype families.  PCR and spoligotyping were performed at 2 different 
times with the same extracted DNA and gave the same result.  The sample was collected 
from a 1 year old child at the paediatric department of NTRH in December 2006. 
 
8 samples were not spoligityped (5 from Hanoi and 3 from the countryside). Spoligotyping 
was attempted two times on all of them, but signals could not be produced, and the 
examination was discontinued. 
 
5.5.2 DNA finger printing results:   
 
In order to specify the difference of reaction bands of mycobacterium strains, a total of 43 
samples (figure 4g) were divided into three groups according to the spoligotyping group 
results. 
 
5.5.2.1 Beijing group:  
 
The large diversity of the 16 samples assigned to this lineage is presented below.  The 
“IS6110 RFLP_Beijing” shows that all of Beijing isolates were different, despite their 
identical spoligotypes. The diversity exceeds 80%. Most isolates carry over 10 copies of 
IS6110 arranged into unique RFLP patterns. 
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The sample named Viet32 harnours three copies of IS6110 and represents a “low-copy 
number Beijing isolate” that is referred to as “atypical Beijing” strain.   
 
 
5.5.2.2  East African Indian and other group:  
 
With only 1 isolate carrying unique RFLP pattern among 11 samples carrying identical 
spoligopatterns of EAI4-VNM (marked * for EAI4-VNM) there were no different level 
respectively, and EAI-5 lineages (marked ** for EAI-5).   
 
The EAI4-VNM family represents the biggest group in EAI families the EAI family present 
in Vietnam during the period of the study research.   
 
On the other hand, the remaining of 5 EAI variants has at least 2 isolates presenting unique 
RFLP patterns and the lineage presented a diversity of up to 80%. 
 
In this group, 9 samples were collected from HNTRH, 4 samples from NTRH and 3 samples 
from TBTRH.   
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Further to the Spoligotyping results, 4 samples named Viet14tb – 19vvs – 24tb and Viet02 
were not got out any isolates into unique RFLP pattern. 
RFLP patterns of 16 isolates assigned the EAI lineage, demonstrating a low diversity based 
on 1-3 copies of IS6110. 
 
 
5.5.2.3 “T” lineage and an undesignated isolate 
 
The isolates assigned to the T-lineage presented unique RFLP pattern.  Their number and 
location of IS6110 copies confirmed a large diversity within this population representing 
70%. 
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The undesignated sample named Viet05N carried a unique RFLP pattern.  The single copy of 
IS6110 was located on DNA fragment of approximately 8 Kbp. 
 
 
A total of 43/56 PCR products were prepared for both spoligotyping and RFLP studies at the 
NIPH. These included 38 samples collected from adults and the remaining 5 isolates 
originated from children (where the gastric lavage technique can be performed only in the 
pediatric department of NTRH). (Table 5.2.2.4)  
 
Table 5.5.2.4:  Distribution of TB strains by IS6110 RFLP and Spoligotyping 
 
 
  Spoligotyping Total 
  not done 
EAI and 
variants Beijing 
T variants 
& others 
LAM 
variants undesignated   
RFLP Not done 8 4 1 0 0 0 13
  done 0 16 17 7 2 1 43
Total 8 20 18 7 2 1 56
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43 samples came form three hospitals in the North of Vietnam: HNTRH, NTRH, TBTRH 
with 16 / 12 / 15 samples respectively; while the difference in number of samples collected 
from these above mention hospitals was small. All of 5 samples from children were collected 
from NTRH. (Table 5.2.2.5) 
 
Table 5.5.2.5:   RFLP results distribution by hospitals 
 
 
 RFLP Total 
  Not done done   
Hospital name HNTRH 5 16 21 
  NTRH 2 12 14 
  TBTRH 6 15 21 
Total 13 43 56 
 
 
 
Geographical strains distribution by spoligotyping 
Belonging to the adult group, the strains distribution is shown in detail below, EAI variants 
were dominant strains in the rural areas while the Beijing strains were abundant in Hanoi city.   
 
Table 5.2.2.6:  TB strains distribution by hospital – geographic in adult group 
 
 Hospital name Total 
 HNTRH NTRH TBTRH   
Hanoi Spoligotyping not done 4 1  5 
  EAI and variants 4 3  7 
  Beijing 8 2  10 
  T and variants 2 0  2 
  LAM variants 1 1  2 
 Total 19 7  26 
Provinces Spoligotyping not done 0 0 3 3 
    EAI and variants 0 0 12 12 
    Beijing 2 1 4 7 
    T and variants 0 1 2 3 
 Total 2 2 21 25 
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5.6 Anti TB drugs resistant related to lineages distribution 
 
36 samples (adult and children) were completed in both of spoligotyping and drug 
susceptibility analysis.  21 (58.3%) samples were demonstrated sensitive with tuberculosis 
drugs while resistance to any drug was observed in 15 (41.7%) and MDR was observed in 7 
(19.4%), (table 4s). 
 
Table 5.6.1:  Relationship between TB strains and anti TB drug resistant 
 
  
 Spoligotyping Total 
 Drug resistant 
EAI and 
variants Beijing 
T and 
variants 
LAM 
variants undesignated  
 Sensitive 10 8 1 1 1 21 
  1 Drug resistant 2 3 3 0 0 8 
  2 drugs resistant 1 1 1 0 0 3 
  3 drugs resistant 1 1 1 0 0 3 
  4 drugs resistant 0 1 0 0 0 1 
Total 14 14 6 1 1 36 
 
 
Among drug resistance strains (samples were collected before treatment), resistance to at 
least 1 drug was observed in 8 (53.3%), resistance to 2 drugs was observed in 3 (20%), 
resistance to 3 drugs was observed in 3 (20.0%) and resistance to 4 drugs was observed in 
1(6.7%) . 
 
 
In adult group:  
 
16 samples were done in susceptibility analysis belong to Hanoi while 15 samples from 
provinces group, among them 6 of any drug resistance belonged to Hanoi were defined 
versus 7 belonged provinces group. (Table 4t) 
 
In general, tuberculosis bacterium strains were defined in this study resistant to isoniazid (H) 
and streptomycin (S) more than rifampicin (R) and ethambuton (E) in both groups.   
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The main difference between Hanoi and provinces group was presented in EAI family:  No 
drug resistance strain was observed in Hanoi versus 3 of any drugs resistance strains in 
provinces, (H: 1, HS: 1, HSE: 1) 
 
 
Table 5.6.2  TB strains and anti TB drug resistant by geographical 
 
  
Living place   Spoligotyping Total 
  
EAI and 
variants Beijing 
T and 
variants 
LAM 
variants   
Hanoi MDR Sensitive 5 4 0 1 10 
    H 0 1 0 0 1 
    HRSE 0 1 0 0 1 
    HS 0 1 1 0 2 
    S 0 1 1 0 2 
  Total 5 8 2 1 16 
Provinces MDR Sensitive 5 3 0  8 
    H 1 0 1  2 
    HRS 0 1 0  1 
    HS 1 0 0  1 
    HSE 1 0 1  2 
    S 0 1 0  1 
  Total 8 5 2  15 
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5.7 Analysis results children group 
 
There were only 5 children recruited during the period of study.  1 (20%) of them belong to 
Hanoi and 4 (80%) belongs to provinces.  2 boys and 3 girls from 1-9 years old were 
collected specimens from gastric lavage respectively.  All analysis techniques were 
conducted successfully in general and DST test in particular with these samples.   
It was defined that, M. bacterium in children resistant to only streptomycin (S) in the period 
on study. 
 
Table 5.7:1 Relationship between MTB strains and anti TB drug resistant by geographical 
 
 
Living place   Spoligotyping Total 
  
EAI and 
variants Beijing 
T and 
variants undesignated   
Hanoi MDR S   1  1 
  Total   1  1 
Provinces MDR Sensitive 0 1 1 1 3 
    S 1 0 0 0 1 
  Total 1 1 1 1 4 
 
 
The characteristics of spoligotyping and RFLP techniques of each samples presented in 
details in the part 4.2.1and 4.2.2 were shown:   
 
A child 9 years old, named Viet03N resistance to streptomycin, was belonged to EAI 4 VNM 
family by spoligotyping (marked *) and one isolate presented unique RFLP patterns, but was 
recorded no TB history contact.   
 
Two thirds of the patients (67%) presented no known tuberculosis history, while 18% had 
experienced treatment falure and 15% had treatment success in the past. 
Table 5.7.2: Tuberculosis history breakdown 
 
67%
18% 
15% 
No TB history 
  Treatment succeeded 
  Treatment false 
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5.8  Multi-bivariate analysis of some risk factors associated with culture positive 
individuals 
 
Culture positive individuals were significant related to alcohol abuse (OR, 1.429; 95% CI, 
0.49-4.20).  Alcohol remained strongly associated with MTB infection when controlled by 
other factor (OR, 2.168; 95% 0.22-2.53).   Most patients over 64 year old were significantly 
more likely to be MTB infected as compared to younger group [odd ratio (OR), 1.677; 95% 
CI, 0.52-5.43].  When controlled for potential confounding factors, this association 
disappeared though (OR, 1.793; 95% CI, 0.44-7.37).  Considering the gender of population, 
culture positive individuals occurred significant in male rather than female, (OR, 1.795; 95% 
CI, 0.51-6.31).  Gender remained strongly associated with MTB infection when controlled by 
other factor (OR, 1.793; 95% CI, 0.44-7.37).  Being a TST negative carried a 1.2 time risk of 
being MTB infected (OR, 1.289; 95% CI, 0.37-4.42).  It seems that smoking was not related 
to risk factor of culture positive infected (OR, 0.456; 95% CI, 0.12-1.65). 
 
 
Table 5.8:  Socio-demographic and other characteristics of MTB culture positive 
 
 Culture % OR 95% CI OR2 95% CI p-value 
 Positive Total       
Age category         
   > 64 20 25 80.00 1.677 0.52-5.43 0.98 0.96-1.04 0.932 
   40 - 64 31 44 70.45 1     
Sex         
   Male 42 55 76.36 1.795 0.51-6.31 1.793 0.44-7.37 0.419 
   Female 9 14 64.29 1     
Smoking         
   Yes 22 32 68.75 0.607 0.21-1.79 0.456 0.12-1.65 0.271 
   No smoking 29 37 78.38 1     
Alcohol         
   Alcohol abuse 30 39 76.92 1.429 0.49-4.20 2.168 0.22-2.53 0.226 
   No 21 30 70.00 1     
TST         
   Negative 35 47 74.47 1.094 0.35-3.43 1.289 0.37-4.42 0.686 
   Positive 16 22 72.73 1     
 
OR, crude odd ratio; OR2, adjusted odd ratio 
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VI. DISCUSSION 
 
Strengths of the study 
 
In a cross sectional study, we could easily to collect exactly subject and can link the data 
items person by person.  It provides the status of an individual with respect to the presence or 
absence or relationship between exposure and diseases at the same point in time.  Cross 
sectional study is most useful for description.  Base on the questionnaire and hospitalized 
patient record we can measure the frequencies of diseases and examine a lot type of variables 
and establish where the risk factor or disease came first.  Convenience sample size allowed 
collect the number of samples as much as possible in a limited time.  
 
The combination of spoligotyping and IS6110 RFLP as probe techniques can discriminate 
exogenous versus endogenous disease, investigate outbreak, study transmission between 
different geographic setting, and detect MTB strains acquired MDR.  More over, those 
techniques conducted in a standardize laboratory in Norway, that ensure the quality of 
outcome. 
 
Trainings for research assistants and pre-testing conducted before data collection ensured a 
standardized way of colleting information and quality of data as well as recruitment patients. 
All of research assistants are doctors and nurse, experienced in clinical medicine and in doing 
research. 
 
Vietnamese language used as mother tongue for interview also reduced misunderstanding 
between interviewers and interviewees. 
 
Limitations of the study: 
 
The sample size was too small to make conclusions on epidemiology in this study.  Besides, 
the bias could not be controlled and was not useful for testing a hypothesis. 
 
Delay to start is the main limitation, lack of skilled staff and low quality infrastructure of 
laboratory at the beginning of the study.  Lack of skilled human resource in conducting 
gastric lavage technique in TB hospitals, there was only a skilled doctor recruited for this 
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activity during the time of study.  Missed children on the way transportation to the hospital 
where gastric lavage technique fulfilled.  Those reasons reduced the sample size of children 
group. 
 
Molecular techniques used very few and were not routine activities in NTP system in current 
time as well as gastric lavage operation. 
 
 
Results of the study 
 
It is widely recognized that TB is coming back worldwide. TB is a high burden disease 
especially in developing countries and a major cause of death in adult in Vietnam in 
particular.    
 
The main finding of this study to map out the difference of MTB strains distribution between 
urban and rural areas and become a reference for comparative studies in the near future.  The 
power of study is not enough to demonstrate a scientifically evidence, but arise clear 
indications of currently different characteristics of MTB in urban versus rural areas 
respectively and may make up a small picture of molecular epidemiology of MTB in current 
time in the northern of Vietnam. 
    
The combination of spoligotyping and DNA fingerprinting techniques in this study will be a 
valuable pre-testing for the author in working in TB areas while molecular analysis is still not 
routine in laboratory system of Vietnam NTP. 
 
The percentage of female presenting to health care services with TB symptoms was lower 
than male in both of urban and rural areas which was consistent with previous studies in 
Vietnam and Ghana (85;86).  In this study, the percentage of female was 23% versus 77% of 
male in adult group.  According to WHO report in 2006, some epidemiological studies 
showed the incidence rates failing among older adult (especially women) but rising among 
younger (especially men) (87).  The main reason could be the fear of social isolation from 
family or community, stigma, gender roles, socioeconomic and level of education described 
in Vietnam in 1999.  However, the mean total delay to TB diagnosis was shown no 
significant difference between men and women (Long et al; Hudelson et al) (88;89).   
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In general, 1-6 months admission’s to hospital after first symptom demonstrated in this study, 
48.7% of sputum symptom, 50% of cough, 40.8% of fever, 38.2% of chest pain, 47.4% of 
exhausted and 47.4% of lose weight in this study in comparison with 13.3 weeks (4 months) 
(95% CI, 11.5, 15.1 Long et al) .  In comparison to previous study conducted in Ho Chi Minh 
City, in Vietnam from April 1997 to January 1998 among 801 patients (90), delay to analysis 
decreased from 81% to 50%-38.2%.   The out come of this study was not focus and a 
limitation to identify the different of delay to diagnosis TB patient between urban and rural, 
but some previous studies specified longer delay in rural than urban areas (91).  However, 
EAI family well established an epidemic in northern of Vietnam during the period of study, 
and those MTB strains dominated in rural areas.   
 
TST 67.8% positive and 32.2% negative in adult group were a little bit different to 72% and 
28% in a previous study in 2003-2004 (Jiri Homolka et al) (92), but only 1.4% of them were 
confirmed BCG vaccinated by research members.  This identification in most adult patients 
who has been previously infected MTB without BCG efficiency, TST should be considered 
using as screening test for non BCG vaccinated population in high prevalence countries of 
TB or not, to avoid increase infection remains question in this study.  (TST may increase 
MTB infection in the non BCG vaccinated population even in low prevalence countries if 
used as a screening test for TB) (93).   
 
Delay to analysis was a risk factor for transmission of MTB in the community, especially 
relating to sputum smear positive (94).   AFB microscopy was the first diagnosis technique in 
community level of Vietnam NTP according to the recommendation in the IUALTD and 
WHO guides.  TB prevalence was 92.653 (10/10.000 of population), AFB positive incidence 
was 59.8%.  To review the AFB test which has been used as the first priority for NTP using 
bacterial culture as a gold standard for diagnosis of tuberculosis (17;95), the sensitive of AFB 
test was accepted at 96.4% while the specificity in this study 77.8% versus 98-99% of 
recently studies in high-prevalence countries (96;97).  The PPV 93.1% and NPV 87.5% mean 
that while those who tested positive, almost certainly positive, among those who tested 
negative, few were positive.  In a screening, this finding presented that most people would 
initially be truly diagnosed as tuberculosis.  If this study has enough power, AFB test will 
still be the first priority for NTP for diagnosis tuberculosis in study located in current time 
while MTB culture remains the gold standard for diagnosis of TB.    
 
Among study population, 78.4% AFB positive versus 21.6% AFB negative were similar to 
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the average percentage of Hanoi and Thai Binh indicators 80.6% and 19.4% respectively, 
(Vietnam Heath statistics book 2003).   
 
In general, the molecular epidemiology in northern Vietnam is dominated by two main MTB 
families: 
  
EAI family was the biggest group of lineages at 41.7% of the total of samples, and 65% of 
those strains belonged to provinces.  There is a well established of EAI epidemic, carrying 
unique RFLP pattern and the spoligotyping pattern and spoligotyping pattern identical for 
EAI4-VNM (marked * in the spoligotyping diagram).  Identical spoligo and RFLP patterns 
would generally indicate an ongoing active transmission of MTB.  The low number of 
IS6110 copies however, urges caution in order to make such conclusions since isolates 
carrying less than 5 copies of IS6110 might not represent recent transmission although their 
RFLP pattern is identical.   The EAI-4 and EAI-5 families with the same characteristic 
IS6110 copies belong to each family respectively, indicated that EAI epidemic as mentioned 
above in which Hanoi contributed 3/8 of EAI-4 and 1/3 EAI-5 in total.  Is there any 
transmission between urban and rural areas when this study was conducted remained 
questionable.  
 
Beijing family was a second main group and contributed 37.5% compare to 46.2% in similar 
age group (Anh DD et al 2000) and 61% of those strains belonged to Hanoi city.  The 
percentage of Beijing lineages was low in this study because they were mostly isolated from 
adult group.  Beijing isolates were separated into unique RFLP pattern despite their identical 
spoligotyping pattern.  This indicated an older epidemic or importation and not a recent 
transmission / outbreak. 
 
20.8% of lineages belonged to “T” family (7 / 10), LAM family (2 / 10) and 1 undesignated 
lineages.   
 
The general characteristics of Beijing, “T” group presented a large diversity.  This might 
present ongoing importation of these lineages.  Although it must be emphasized that the 
current population is small and does not represent the complete epidemiological picture in 
northern of Vietnam.  However few isolates were closely related to other isolates within this 
population, such observations are generally characteristic for populations that have not 
evolved locally.  
 54
 
Anti TB drug resistance:  among 74 samples of this study, resistance to any drug was 
observed in 15 (20,3%) versus 26.3% ; resistance to isoniazid 10/74 (13.5%) versus 16.6%; 
resistant to Rifampicin 2/74 (2.7%) versus 2.0%; resistance to Ethambuton 3/74 (4.1%) 
versus 1.1%; resistance to Streptomycin 10/74 (13.5%) versus 19.4% respectively.  Besides, 
among 24 treated patients in this study; any drug resistance was 5/24 (20.8%) and MDR was 
2/24 (8.3 %) versus and 62.9% and 23.2% (Huong et al), but the sample size in this study was 
too small to make any conclusion about the difference of these figures  (98). 
 
In adult patient group, the difference arises between urban and rural group if the combination 
of molecular epidemiology with MDR is made.  The main difference between Hanoi and 
provinces group was presented in EAI family:  No MDR in Hanoi versus one drug resistance 
and two MDR strains were defined in provinces, (Viet25tb resistance H, Viet16tb resistance 
HS and Viet 11tb resistance HSE).  EAI-4 VNM and EAI-5 families in northern Vietnam 
present the same characteristics in molecular and MDR epidemiology as sensitive with anti-
TB drugs (excluded Viet11tb and Viet16tb resistance at least 1 drug).   It seems that, the 
cross transmission in the northern Vietnam occurred during the time of study.   
 
TB risk factors in adult population of this study associated between culture positive or active 
TB with alcoholism (p=0.226) and male (p=0.419), however the limitation of sample size 
make difficult to conclude a significant evidences.  Age and smoking were less relationship 
with TB risk factors. 
 
21.4% of Hanoi and 18.5% of rural patients unconfirmed with HIV test result in this study, 
remain as a remarkable point in HIV/TB control activity.   
 
As the children population was too small and is presented here only as additional 
information, no dominant TB family related to the geographical difference was found.  TB 
transmission occurred in a 9 years old child from rural area, belonged to EAI4 and resistant to 
Streptomycin.  2 strains belonged to “T” family (including 1 resistant to Streptomycin), and 1 
strain belonged to Beijing family.  The last strain was an undesignated strain and no 
examination was followed. 
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VII. CONCLUSION AND RECOMMENDATION 
 
CONCLUSION 
 
Despite the presence of several M. tuberculosis lineages and the large genetic diversity in the 
M. tuberculosis population presented in northern Vietnam, spoligotyping should be 
considered as a valuable screening method for clustering of M. tuberculosis isolates and their 
assignment to known genotypes. Also the affordability reproducibility of the method is an 
advantage.   
 
Further research into the presence of putative emerging strains and the risk of transmission of 
specific M. tuberculosis lineages seems to be necessary in order to improve the effectiveness 
of the National Tuberculosis Program in Vietnam. 
 
The sample size of this study was too small to conclude what strains are emerging. However, 
the variation within each of the major strains/families and the urban-rural difference make it 
possible to hypothesize that the East Africa India family is well established which seems to 
present a recently cross transmission between urban and rural areas while Beijing and other 
families continue to be imported in northern of Vietnam. 
 
RECOMMENDATION 
 
9 To consider spoligotyping method for screening MTB as a standard method in all 
reference laboratories of NTP provinces 
 
9 To focus on education of public on risk of infection.  
 
9 To maintain Immunization and monitoring.  
 
9 To make decision makers (health and politicians) aware of the potential risk and 
danger of MRD TB in Vietnam 
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ANNEX 1: MOLECULAR METHODS 
 
Laboratory method: 
Molecular biology analysis will be carried out at NIPH, Norway in the 1st quarter of 2007 
because of PCR, Spoligotyping and RFLP are not routine analysis in home country during the 
research time. 
 
1 Isolation of high molecular weight genomic DNA from Mycobacteria 
The method of choice is determined by the amount of starting material, the desired amount 
and purity of DNA isolated, and the nature of the materials from which the DNA is to be 
extracted.  DNA isolated by most miniprep protocols contains significant RNA contamination 
which can interfere with DNA digestion and with hybridization of the southern blots.  RNA 
can be removed either by digestion of the entire sample with DNase-free RNase after 
preparation, or at the same time as restriction endonuclease digestion (20). 
Isolation and extraction of high molecular weight genomic DNA from Mycobacterium (82). 
Caution:  for mycobacterium pathogenic to humans appropriate containment facilities should 
be used while handling before heat-inactivation. 
Transfer at least two loops of mycobacterium into a micro centrifuge tube containing 400 
μl of 1X TE  
Kill the cells by heating for 20 minutes at 80oC, and cool at RT 
Put the CTAB/NaCl solution at 65oC, (for use in step 6) 
Add 5 μl proteinase K (10 mg/ml) – mix lightly 
Add 70 μl of 10% SDS,   mix them and vortex, and incubate for 10 – 15 minutes at 65oC 
Add 100 μl of 5M NaCl and 100 μl of pre-warmed CTAB/NaCl solution (step 3), and 
vortex until the liquid content becomes white (“milky”) (or mix them 10 – 20 seconds).  
Incubate for 10 minutes at 65oC 
Add 750 μl of Chloroform/isoamyl alcohol and vortex for at least 10 seconds 
Centrifuge for 5 minutes at 13,000 rpm 
Transfer the aqueous phase (upper layer) to a fresh micro centrifuge tube, by pipetting 
small aliquots of e.g. 180 μl 
Add 450 μl (0.6 volume) of isopropanol – mix well 
Manually move the tube slowly upside down to precipitate the nucleic acids and estimate 
the amount of 1X TE in which the DNA should be redissolved in step 20.  write the 
estimated volume e.g. on the tube 
Place at -20oC for at least 30 minutes (± over night) 
Extraction 
Take out from Freezer, place it in RT 
Centrifuge in 10 minutes at 13,000 rpm 
Discard most of supernatant, leave about 20 μl (3mm height) above the pellet 
Add 900 μl of cold 70% Ethanol (from the -20oC freezer) and turn the tube a few time 
upside down to wash the DNA precipate.  Note: 70% (70ml 100% and 30 ml H2O) 
Centrifuge in 10 minutes at 13,000 rpm 
Discard most of the supernatant; leave about 20 μl (3 mm height) above the pellet 
Upside down the tube and dry at 37oC in 30 minutes 
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Add 20 μl of TE buffer (1X TE) to dissolve DNA  
Vortex 
Place in freezer – 20oC 
 
2. DNA concentration determination 
Before further analysis, it is important to determine the concentration and condition of the 
DNA that you have isolated.  This can be done in three ways: by examining UV absorbance 
with spectrophotometer, by fluorimetry, or by comparison with DNA standard on agarose 
gels. 
DNA prepared by miniprep protocols often contains a large amount of RNA and pigments 
that can cause spuriously high estimation of DNA concentration on a spectrophotometer.  For 
this reason 0.8% agarose gels are useful for assessing both the quantity and the quality of 
genomic DNA (is it high molecular weight, or is these substantial shearing or degradation?) 
and the amount of RNA present (20). 
DNA check 
Prepare 0.8% gel - 1.2 gram ME Agarose 
150 ml TBE 1X buffer 
boiling 2 a.m chemicals together in micro oven  
and get cold at 60oC 
Solidify in 30 – 45 minutes 
100 V = program 1 
Make a list of samples 
Take samples out of Freeze 
Labeling new tubes with as same as samples 
Melt samples, then take out of each sample 1 μl add to new tube 
Add 9 μl 1X DNA sample buffer (m/Rnaze) 
Apply 10 μl of gel (+ 5μl ladder) 
Run program 1 (2 hours) Can keep overnight at 4oC 
Dye Gel with m/ ethidium bromid in 15 minutes  
Dye off (shake) with distilled water in 20 minutes (or 10 minutes + 10 minutes) 
Photographer (82) 
 
3 Restriction endonuclease digestion of DNA 
 
Digestion of DNA with restriction endonuclease that cleave at different recognition sites lies 
at the heart of RFLP analysis.  Complete digestion is essential to obtaining interpretable 
RFLP patterns.  Several factors affect endonuclease activity, including pH, concentration, and 
type of ions in the buffer, and the temperature of the reaction (20). 
 
Cutting DNA with restriction enzyme 
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We use PVU II (Restriction endonuclease) in order to cut DNA as follow: 
CAG|CTG 
GTC|GAC 
Take out samples from freeze 
Labeling new eppendofts  
Transfer 9 μl DNA to each eppendoft and place on the ice 
Add 2 μl M buffer 
Add 8 μl distilled water 
Add 1 μl PVU II, mixes 
Mixes 
Centrifuge at 1300 rpm (increase to 1300 rpm and slow down) 
Put all these eppendoft to water-bath at 370C in 2 hours or over night 
Note:  If the DNA concentration weak, we can increase the volume of DNA more than 9 μl 
and decreased the volume of distilled water – but the total of DNA and distilled water must 
be 17 μl 
 
Add 5 μl 1x DNA sample buffer m/ RNA’se 
Put into refrigerator (2-80C) 
Could be kept in several months, but avoid to dry samples (82) 
 
4  Separate DNA fragment with electroforese “night gel” 
 
The size range of fragments that results from digestion of most DNAs makes agarose the idea 
matrix for size fractionation of the resulting DNA fragments by electrophoresis. Gels of 0.8% 
agarose are useful for the broadest range of fragment size encountered in routine analysis 
(20). 
Make 0.8% gel:  1.2 gram ME Agarose 
150 ml TBE 1X buffer 
Use distilled water (pick up at 1st floor) whenever keep gel and buffer 
bottle 
Add 8 μl ladder 1:5 
Add 12 μl of sample 
Run program 2 (100v in 10 minutes, 25v in 18 hours) 
Dye gel and photograph 
We could use vacuum blotting (82). 
 
DNA transfer to membrane 
 
DNA fragments are generally transferred from the electrophoresis gel matrix and bound to a 
membrane for subsequent hybridization to the probe of choice.  For all protocols, the quality 
of the resulting membrane is dependent upon careful handling of the gel, membrane, and 
filter paper that comes in contact with the membrane (20). 
 
 
Vacuum Blotting 
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Principle: 
Vacuum gene XL is a system in order to transfer acid nucleic from gel to membrane (gene 
screen). 
Rapid carry out:   
Method namely Southern Blotting, it combines electroforese gene (analysis DNA fragments 
by size) and hybridization with sample, it find out DNA sequence 
First of all, DNA is disengaged to simple DNA fibers and put into nylon membrane.  After 
blotting, all fibers of DNA of gene will be transferred and fixed in membrane.   
UV fixed DNA to membrane (DNA face down) 
 
Use Gloves 
Cut gene screen 11 x 17 cm 
Damp screen (a soft polyethylene) by water, put it into o square pot, smooth face on top 
Put the membrane into middle of screen 
Mask of 0.15 mm polyethylene with a window appropriate with membrane 
Cut Gel and put over the mask 
Put square pot to the mould 
Close 4 clips 
Fit a plastic pipe in to mould, make sure it is close tight 
Tight of glass bottle and start vacuum 
Keep the pressure about 50 mbar 
 
Flush 50 ml 0.25 M HCL (cool HCL) on the Gel, make sure that the depurination solution 
cover all gel 
Keep in 7 minutes 
Lean the square pot, use the glove to push out the HCL from gel 
Suck out HCL 
Close the pipe 
Keep the pressure at 50 mbar again 
Flush 50 ml 0.5 MNAOH m/1.5 MNACL (denaturalization solution) in to the Gel 
And make sure the solution cover all gel 
Keep 20 minutes 
Check the pressure of vacuum at 50 mbar 
Lean the square pot, push out the solution by finger 
Suck out solution 
Close the pipe 
Keep the pressure at 50 mbar again 
Flush 50 ml 1M tris HCL m/1.5 MNACL pH 7.5 (neutralization solution) cover all gel 
Keep in 20 minutes, make sure the pressure at 50 mbar 
Suck out the solution 
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Flush 750 ml 20X SSC (transfer solution) until cover black mark of mould, avoid the gel 
floating 
Keep 60 minutes 
Make sure the vacuum pressure at 50 mbar 
Suck out the solution 
Put out the gel, turn off the vacuum 
Put the gene screen on the filter paper, dry it in RT about 30 minutes (may change the 
filter paper at this time) 
Put the gene screen on the dry and clean filter paper and pack it with plastic paper 
UV illuminuteate in 5 minutes (DNA face down without plastic) 
Keep in refrigerator 
Note:  all bottles needs to be kept in refrigerator (82). 
 
6  Hybridisation with Probe 
 
This plastic membrane will be hybridized in a solution which is included a probe namely dig 
and a ladder namely dig. 
The probe must be included the DNA sequence which are we want to find out.  When we 
increase the temperature of probe? Sample will be denatured and hybridized with the same 
basic XL.  The materials of probe/ samples which are not combined together will be losing 
after flush…. 
 
Solution for pre-hybridization 
Use for 1 filter 
-  1g blocking reagent     (in refrigerator) 
-  25 ml 20 X SSC     (RT) 
-  1 ml 10% Sarcosyl    (in refrigerator) 
-  200 μl 10% SDS     (RT)  
-  Full fill 1000 ml m/sterile water (before SDS) 
Mix them in an infusion bottle of 500 ml distilled water 
Put and shake in the water bath 680C in one hour 
Take out the pre-hybridization from water bath… 
Put the filter to a plastic box (make sure the filter fit with plastic box and DNA face down) 
Add 80 ml pre-hybridization to plastic box and keep the rest of liquid 
Put the lid on the plastic box 
Place and shake the plastic box in water bath 600C in 2 hours 
Note: put a heavy material over the plastic box 
 
Hybridization solution  
25 μl dig marked probe (keep in freeze – 200C) 
2,5 μl dig marked ladder (keep in freeze – 200C) 
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10 ml pre-hybridization 
Dig marked probe and ladder keep in freeze of laboratory, make warm and place on the ice 
before use 
After use with pre-hybridization, can freeze and reuse for 3 times.  Make sure to mark 
number of use 
Take out the hybridization from freeze, make warm at RT or refreeze 
Denaturisation probe and ladder before hybridization 
Add warmed solution to glass tube with lid 
Boiling in microwave oven, make sure fill solution as least a haft of glass tube 
Put into the ice in 10 minutes 
(note: make sure enough 10ml hybridization solution) 
 
Use a big glass tube with green lid for hybridization (gloves) 
Take out the filter box form water bath 
Role up the filter as same as cigar 
Use a pinsett put the cigar filter to glass tube 
Use glass pipette take out the air bubbles if needed 
Add denaturisation to the filter glass tube 
Put the glass tube to the hybridization machine, at 600C overnight 
(note:  we need to put a other glass tube with the same volume at opposite side) 
Clean plastic boxes with soap and dry  
 
Next day:   
Turn off the hybridization machine; take out the Filter glass tube 
Clean the filter and make colors in order to see DNA 
Clean all tube with soap, and dry 
 
7 Buffers will be used for cleaning and dye colors 
 
Sterile bottle and tube must be placed at glass cleaner room some days before 
Put in to the water bath with buffer 2 in 1 hour at 680C 
 
Marked one bottle (1L): 0.1x SSC / 0.1 % SDS (measure level) 
About 5 ml 20 X SSC 
10 ml 10% SDS (last one) 
Full fill 1L m/ distilled water 
Mix and lid sterile 
Marked one bottle (1L): 2x SSC / 0.1 % SDS (measure level) 
100 mg 20 X SSC 
10 ml 10% SDS (last one) 
Full fill 1L m/ distilled water 
Mix 
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Marked one bottle (1L): Buffer 1 and measure level 
100 ml tri HCL pH 7.5  (refrigerator) 
50 ml 3M NACL  (refrigerator) 
Full fill 1L m/ distilled water 
Mix 
Only use in one day (all 3 above mention bottles)/ except SSC in RT 
 
Marked one bottle (1L): Buffer 2 (measure level) 
1g of blocking reagent (refrigerator) 
200 ml buffer 1 
Dissolve in water bath 680C in 1 hour 
Marked one bottle  Buffer 3 (measure level) 
100 ml 1 M Tri Hcl pH 9.5 (refrigerator) 
33.3 ml 3M Nacl  (refrigerator) 
50 ml 1 M Mgcl2  (refrigerator) 
Full fill 1L m/ distilled water 
(Can be used in 1 month – marked the date on the bottle – keep in RT) 
Turn on the water bath with shake at 680C 
 
Use gloves 
Take out the hybridization tube from hybridization machine 
Add to plastic box 100 ml 2 X SSC / 0.1 % SDS 
Use pinsett put out the filter from glass tube and place to the above mention box (the rest of 
hybridization liquid can be keep in other tube and frozen) 
Shake the tube and through out the liquid 
Add 500 ml 2X SSC / 0.1 % SDS 
Shake 5 minutes at RT, 2 times (make sure the speed of shaking machine, avoid through out 
liquid) 
Through out liquid after shaking, repeat 1 time 
Add 500 ml 0.1 X SSC / 0.1 % SDS 
Shake twice in the water bath in 20 minutes at 680C, through out the liquid 
Now, use o big plastic cover Petri, place the filter inside 
Add 100 ml Buffer 1 
Shake in 1 minute at RT 
Through out buffer 1 
Add 200 ml buffer 2 
Shake in 30 minutes at RT 
Through out buffer 2 
Add 100 ml Buffer 1 
Shake 1 minute at RT 
Through out buffer 1 
Add exactly 80 ml buffer 1 and {16 μl DIG DNA labeling and detection kit} direct to the 
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plastic cover Petri on the shaking machine (N08) 
Shake 30 minutes at RT 
Through out liquid 
Rinse twice 15 minutes in 100 ml buffer 1 (shake) 
Rinse 2 minutes with 80 ml buffer 3 
 
Prepare dye solution exactly: 
40 ml buffer 3 
Add 800 μl NBT / BCIP (freeze – N09) 
Put in to one box and put the filer in (place the DNA side down) 
Pack the filter box in aluminuteum paper, place in dark (drawer) in 24 hours 
Rinse filter with distilled water 
 
8 Prepare the STOP – MIX solution 
 
3 ml tris/Hcl – buffer 1.0M pH 8.0 
1.5 ml 0.2M EDTA NA2 2H20 
295 ml distilled water 
Measure water level in 500 ml tube 
 
Through out dye solution 
Rinse sometime with distilled water 
Rinse sometime with STOP – MIX solution 
Fill in the rest of solution in box, keep filter in the box some hours (can be left for several 
days) 
Place filter on the filter paper at RT to dry 
Clean all tube with water (82). 
 
II Spoligotyping:   
 
The typing method is based on DNA polymorphism present at one particular chromosomal 
locus, the “Direct Repeat” (DR) region, which is uniquely present in mycobacterium 
tuberculosis complex bacteria.  With the method described here, the presence or absence in 
the DR of 43 spacer of known sequence can be detected by hybridization of PCR-amplified 
spacer DNA to a set of immobilized ologonucleotides, representing each of the unique spacer 
DNA sequences.  This method will be referred to as spoligotyping (from spacer oligotyping)  
1 PCR: Polymerase chain reaction (PCR) – Gene amplification methods (PCR as well as 
isothermal) developed for the diagnosis of tuberculosis is highly sensitive especially in 
culture-negative specimens from paucibacillary forms of disease. A variety of PCR 
techniques have been developed for detection of specific sequences of Mycobacterium 
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tuberculosis and other Mycobacteria (19).  PCR defined segments of DNA can be 
amplified to microgram quantities from as little as single template molecule.  Although the 
procedure is in some way deceptively simple, and the reaction can entail complex 
biochemical interactions, it is in most application a fast, relatively inexpensive and easy 
way to generate ample materials for further analysis (20). 
 
In this research, the last region of the Mtb genome, where is located the direct repeats 
namely A; B; C; D will be amplified by primes DRa and prime DRb.  Amplification of 
the spacers is accomplished by using the primers DRa and DRb, which enable to amplify 
the whole DR (direct repeat) region.  Only a very small amount of template DNA is 
required.  Typically the PCR is performed on 10ng purified chromosomal Mycobacterial 
DNA but, with minor adaptations, DNA extracts from clinical samples from freezer can 
server as template.  The PCR products are labelled with Biotin, because one of the 
primers is biotinylated.  The primers of PCR are based on the DR sequence: 
DRa: 5’ – GGT TTT GGG TCT GAC GAC – 3’, biotinylated at 5’ end 
DRb: 5’ – CCG AGA GGG GAC GGA AAC – 3’ 
Procedure: 
Dilute the DNA samples to the required concentration.  Always include chromosomal DNA 
of M.tuberculosis strain H37Rv and M.bovis BCG as positive controls.  Use water as a 
negative control (99). 
 
Prepare the reaction mixture: 
DNA product 02 µl  
10x PCR 05 µl  
Place the tubes in a PCR-apparatus for 
amplification, and perform the following 
temperature cycling: 
Primer DRa 04 µl  2 minutes at 960C  
Primer DRb  04 µl  
dNTP mix 04 µl  
Tag 0.25 µl  
1 minute 960C 
1 minute 550C 
30 seconds 720C 
 
 
 
 
 
30 cycles 
 
H20 30.75 µl  5 minutes at 720C 
 
2 Hybridization with PCR product and detection 
 Hybridization of biotin-labeled PCR products to the immobilized spacer-oligos that represent 
spacers of known sequence.  The presence pf spacers are visualized on film as black squares 
after incubation with streptavidin-peroxidase and ECL-detection. 
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Procedure:   
All buffers should be pre-warmed before use.  Prepare the following buffer from 
concentrated stocks, using demineralised water for dilution (quantities for one 
membrance): 
  250 ml 2xSSPE/0.1% SDS, 600C 
  500 ml 2xSSPE/0.5% SDS, 600C 
  500 ml 2xSSPE/0.5% SDS, 420C 
  500 ml 2xSSPE, room temperature 
Add 25 µl of PCR products to 150 µl 2xSSPE/0.1% SDS 
Heat-denature the diluted PCR products for 10 minutes at 990C and cool on ice 
immediately 
Wash the membrane for 5 minutes at 600C in 250 ml 2xSSPE/0.1% SDS 
Place the membrane and a support cushion into the miniblotter, in such a way that the 
slots are perpendicular to the line pattern of the applied oligonucleotides. 
Remove residual fluid from the slots of the miniblotter by aspiration 
Fill the slots with diluted PCR product (avoid air bubbles) and hybridize for 60 minutes at 
600C on a horizontal surface (no shaking).  Avoid contamination of neighbouring slots. 
Remove the samples from the miniblotter by aspiration and take the membrane from the 
miniblotter using forceps 
Wash the membrane twice in 250ml 2xSSPE/0.5% SDS for 10 minutes at 600C 
Place the membrane in a rolling bottle and allow it to cool down to prevent inactivation of 
the peroxidase in the next step 
Add 2.5 µl streptavidin-peroxidase conjugate (500U/ml) to 10 minutes at 420C 
Rinse the membrane twice with 250 ml of 2xSSPE for 5 minutes at room temperature 
For chelmiluminiscent detection of hybridizing DNA, incubate the membrane for 1 
minute in 20 ml ECL detection liquid (10ml ECL 1 and 10 ml ECL 2) 
Cover the membrance with a transparent plastic sheet or saran-wrap and expose a light 
sensitive film to the membrane for 20 minutes. 
If the signal too weak or too strong the membrane can be used again directly to expose 
another film for a shorter or longer period (99). 
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ANNEX 2 
 
DATA COLLECTION FORM 
University of Oslo, Norway 
National Institute of hygiene & 
Epidemiology 
National Tuberculosis & Lung 
Diseases 
         
DATA COLLECTION FORM  
 
        
   Date of admission:  ......./........./........ Study code: .............................. 
   Department:................................. Archive No:............................................. 
   Bed No:...................................... Medical code.........../................../............ 
General Information       
1 Full name: ........................................ 2 Date of birth  …./…./…… 
3 Gender 
(1) 
Male:  (2)Female:  4 Ethnic: ................................................................. 
5 Address:  No.................Street....................................Commune.............................................  
 District.............................................................................City.....................................  
6 Nationality  (1) Vietnam   
(2) 
Foreigner    
7 Place of work ......................................................................................................................................... 
8 Telephone No  (1) Desk.................................  (2) Mobile............................................ 
9 Smoker  (1) No    
(2) Yes
    
10 Alcohol  (1) No    
(2) Yes
    
11 TB related to contact persons:   (1) No   
(2) Yes 
  
12 History of Immunization of BCG: (1) with scar  (2) No scar      
  (3) Immunization card   
(4) Other
 ........................................................ 
Symptoms  
 
     
13  a b c d e f g 
 
 
No Yes > 1 week 1-4 week 1-6 m 1/2 -1 year > 1 year 
a 
Spitting & 
Sputum        
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b Cough        
c Fever        
d Chest pain        
e Fatigue        
f Weight loss        
14 Other clinical symptoms if any      
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History        
15 Have you been treated for TB ..................time before? When, Where, for how long, Result? 
         
                 
Paraclinic information       
16 Sputum examination Result 1 (1) Positive  
(2) 
Negative  
   Result 2 (3) Positive  
(4) 
Negative  
   Result 3 (5) Positive  
(6) 
Negative  
17 Culture  Result  (1) Positive  
(2) 
Negative  
18 Mantoux  Result  (1) Positive  
(2) 
Negative  
19 HIV   Result  (1) Positive  
(2) 
Negative  
20 X-ray        
                 
21 
CT 
Scanner:        
         
         
22 Ultrasound        
         
23 PCR:        
         
         
24 RFLP        
 Clustered strains: 
(1) No  
  
(2) Yes  
    
 No of  copy IS6110:       
         
Patient's signature   Name of patient   
         
                 
         
Signature of interviewer   Name of patient   
         
                 
         
Signature of study Director   Name of patient   
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University of Oslo, 
Norway 
National Institute of hygiene & 
Epidemiology 
National Tuberculosis & Lung 
Diseases 
         
DATA COLLECTION FORM ( SOURCE OF INFECTION ) 
 
        
      Study code……………….. 
   Department:............................................... Archive No …………………. 
   Bed No   Medical code………/…………/ 
         
 Full name: ........................................... 2 Date of birth  …./…./…… 
Source of TB        
25 No of TB infected in the family  ……    
26 Full name: ........................................... 27 Date of birth …./…./…… 
28 Gender 
(1)Male: 
 (2)Female:  29 Ethnic: ....................................................... 
30 Address:  No.................Street....................................Commune.............................................  
 District.............................................................................City..................................   
31 Nationality  (1) Vietnam:   
(2)  
Foreigner    
32 Place of work ........................................................................................................................ 
                 
         
33 Full name: ................................... 34 Date of birth …./…./…… 
35 Gender 
(1)Mal
e:  (2)Female:  36 Ethnic: ........................................................ 
37 Address:  No.................Street....................................Commune.............................................  
 District.............................................................................City.....................................   
38 Nationality  (1) Vietnam:   
(2)  
Foreigner    
39 Place of work 
....................................................................................................................................
............................................................. 
                 
40 No of people being infected with TB  ……    
41 Full name: ........................................... 42 Date of birth …./…./…… 
43 Gender 
(1)Mal
e:  (2)Female:  44 Ethnic: .......................................................... 
45 Address:  No.................Street....................................Commune.............................................  
 District.............................................................................City.....................................   
46 Nationality  (1) Vietnam:   (2)     
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Foreigner 
47 Place of work .................................................................................................................................... 
                 
         
48 Full name: ................................... 49 Date of birth …./…./…… 
50 Gender 
(1)Mal
e:  (2)Female:  51 Ethnic: .......................................................... 
52 Address:  No.................Street....................................Commune.............................................  
 District.............................................................................City.....................................   
53 Nationality  (1) Vietnam:   (2)  Foreigner    
54 Place of work ......................................................................................................................... 
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ANNEX 3 
CONSENT FORM 
 
 I am ………………………….. from a research team established by Department of International 
Health, University of Oslo-Norway, NTRH and Molecular Biology Department - NIHE. I am here to 
conduct a study on Tuberculosis among children less than 15 years and adult over 40 years of age 
admitted to National Institute of Tuberculosis from September to November 2006. The study is trying 
to find out the different successful strains of Mycobacterium Tuberculosis between children and adult. 
If BCG proves inactive in preventing new strains of MTB, a new or modified vaccine will be needed 
for EPI program in Vietnam in the future.  I would like to interview you, and ask you for your 
permission to collect MTB strains sample (Gastric lavage) from you and your own child. 
 I have a few questions about Tuberculosis and related issues. Your answers will be written and 
then used for analysis. All information you provide will be handled as confidential and your personal 
answers will not be known, except by the interviewer and the coordinator of this study. The results 
will be used only to improve strategies for prevention of Tuberculosis by vaccination, one of the most 
burden diseases in Vietnam. 
 We will need at least 30 minutes to discuss and record the information. You can withdraw from 
the interview at any stage without any consequence if you do not wish to continue. 
Will you participate in this study?     Yes □     No □ 
Do you have any question? 
Thank you. 
Date: …../……./2006. 
 
Interviewee’s signature: ………………… 
 
Interviewee’s signature: ………………… 
Interviewee’s signature: ………………… 
 
Interviewee’s signature: ………………… 
 
